ChampionX (CHX) 10-K 5 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) shares in Millions	12 Months Ended
	Dec. 31, 2024	Jan. 31, 2025	Jun. 28, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-38441
Entity Registrant Name	ChampionX Corp
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-3066826
Entity Address, Address Line One	2445 Technology Forest Blvd
Entity Address, Address Line Two	Building 4, 12th Floor
Entity Address, City or Town	The Woodlands,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77381
City Area Code	281
Local Phone Number	403-5772
Title of 12(b) Security	Common stock, $0.01 par value
Trading Symbol	CHX
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction	false
Entity Shell Company	false
Entity Public Float			$ 6,284,460,974
Entity Common Stock, Shares Outstanding		190.8
Documents Incorporated by Reference	Portions of the registrant’s definitive proxy statement relating to its 2025 annual meeting of shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated, or such information will be included in an amendment to this Form 10-K in accordance with Instruction G(3) of Form 10-K.
Entity Central Index Key	0001723089
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	238
Auditor Location	Houston, Texas

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Lease and other revenue	$ 115,157	$ 96,484	$ 87,727
Total revenue	3,633,983	3,758,285	3,805,948
Cost of goods and services	2,445,281	2,618,646	2,907,284
Gross profit	1,188,702	1,139,639	898,664
Costs and expenses:
Selling, general and administrative expense	720,632	633,032	592,282
Goodwill impairment	0	0	39,617
(Gain) loss on sale-leaseback transaction and disposal group	(29,826)	12,965	18,493
Interest expense, net	55,868	54,562	45,204
Foreign currency transaction losses, net	2,490	36,334	8,555
Other income, net	(3,337)	(21,078)	(2,293)
Income before income taxes	442,875	423,824	196,806
Provision for income taxes	115,746	105,105	40,243
Net income	327,129	318,719	156,563
Net income attributable to noncontrolling interest	6,863	4,481	1,594
Net income attributable to ChampionX	$ 320,266	$ 314,238	$ 154,969
Earnings per share attributable to ChampionX:
Basic (in dollars per share)	$ 1.68	$ 1.60	$ 0.77
Diluted (in dollars per share)	$ 1.65	$ 1.57	$ 0.75
Weighted-average shares outstanding:
Basic (in shares)	190,578	196,083	201,740
Diluted (in shares)	193,643	199,906	207,259
Product revenue
Revenue:
Revenue	$ 3,118,347	$ 3,297,468	$ 3,318,357
Service revenue
Revenue:
Revenue	$ 400,479	$ 364,333	$ 399,864

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 327,129	$ 318,719	$ 156,563
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(46,286)	(916)	(18,592)
Cash flow hedges	3,210	(5,464)	7,558
Pension and other post-retirement benefit plans	(918)	(616)	3,129
Other comprehensive loss	(43,994)	(6,996)	(7,905)
Comprehensive income	283,135	311,723	148,658
Less: Comprehensive income attributable to noncontrolling interest	6,863	4,481	1,594
Comprehensive income attributable to ChampionX	$ 276,272	$ 307,242	$ 147,064

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 507,681	$ 288,557
Receivables, net of allowances of $5,118 in 2024 and $5,734 in 2023	466,782	534,534
Inventories, net	496,831	521,549
Prepaid expenses and other current assets	92,603	80,777
Total current assets	1,563,897	1,425,417
Property, plant and equipment, net of accumulated depreciation of $849,465 in 2024 and $781,367 in 2023	755,422	773,552
Goodwill	718,944	669,064
Intangible assets, net	258,614	243,553
Operating lease right-of-use assets	100,427	69,561
Other non-current assets	72,948	60,555
Total assets	3,470,252	3,241,702
Current Liabilities:
Current portion of long-term debt	6,203	6,203
Accounts payable	455,531	451,680
Accrued compensation and employee benefits	113,907	109,626
Current portion of operating lease liabilities	16,794	23,292
Accrued distributor fees	0	56,443
Accrued expenses and other current liabilities	193,437	135,505
Total current liabilities	785,872	782,749
Long-term debt	591,453	594,283
Deferred income taxes	62,373	71,497
Operating lease liabilities	81,340	41,975
Other long-term liabilities	118,036	90,167
Total liabilities	1,639,074	1,580,671
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 190.7 million shares and 191.3 million shares issued and outstanding at December 31, 2024 and 2023, respectively	1,907	1,913
Capital in excess of par value of common stock	2,164,098	2,166,911
Accumulated deficit	(239,048)	(455,676)
Accumulated other comprehensive loss	(80,520)	(36,526)
ChampionX stockholders’ equity	1,846,437	1,676,622
Noncontrolling interest	(15,259)	(15,591)
Total equity	1,831,178	1,661,031
Total liabilities and equity	$ 3,470,252	$ 3,241,702

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Receivables, allowances	$ 5,118	$ 5,734
Accumulated depreciation on property, plant and equipment	$ 849,465	$ 781,367
Common stock, shares authorized (in shares)	2,500,000,000	2,500,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	190,700,000	191,300,000
Common stock, shares outstanding (in shares)	190,700,000	191,300,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash provided by (used for) operating activities:
Net income	$ 327,129	$ 318,719	$ 156,563
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	245,825	235,936	241,880
(Gain) loss on sale-leaseback transaction and disposal group	(29,826)	12,965	16,515
Loss on Argentina Blue Chip Swap transaction	7,086	0	0
Loss on goodwill and long-lived asset impairments	0	0	39,617
Stock-based compensation	25,770	23,749	20,089
Provision for inventory obsolescence and write-downs	12,833	18,974	26,336
Loss on debt extinguishment and modification	0	0	4,043
Deferred income taxes	(22,873)	(22,272)	(45,282)
Loss (gain) on disposal of fixed assets	(443)	(1,046)	(1,683)
Amortization of deferred loan costs and accretion of discount	4,239	4,103	3,751
Other	6,408	5,948	1,888
Changes in operating assets and liabilities:
Receivables	76,569	70,021	(23,988)
Inventories	(8,924)	18,753	(52,426)
Leased assets	(33,767)	(51,247)	(25,275)
Other assets	(15,152)	20,395	(1,838)
Accounts payable	(399)	(53,891)	(13,366)
Other liabilities	(4,794)	(60,836)	66,536
Net cash provided by operating activities	589,681	540,271	413,360
Cash provided by (used for) investing activities:
Capital expenditures	(141,310)	(142,324)	(102,808)
Proceeds from sale of fixed assets	12,113	14,545	18,017
Proceeds from sale-leaseback transaction	44,292	0	0
Acquisitions, net of cash acquired	(123,269)	0	(3,198)
Purchase of investments	(31,526)	0	0
Sale of investments	24,358	0	0
Net cash used for investing activities	(215,342)	(127,779)	(87,989)
Cash provided by (used for) financing activities:
Proceeds from long-term debt	0	15,500	995,038
Repayment of long-term debt	(6,203)	(45,176)	(1,092,950)
Payment of debt issuance costs	0	(1,028)	(8,008)
Dividends paid	(70,531)	(64,980)	(45,594)
Repurchases of common stock	(49,399)	(277,575)	(180,142)
Payments related to taxes withheld on stock-based compensation	(12,561)	(9,763)	(11,964)
Proceeds expected to be remitted under the Accounts Receivable Facility	6,297	17,298	18,239
Payment of finance lease obligations	(13,838)	(9,982)	(6,540)
Other	(4,222)	2,541	7,116
Net cash used for financing activities	(150,457)	(373,165)	(324,805)
Effect of exchange rate changes on cash and cash equivalents	(4,758)	(957)	(5,557)
Net increase (decrease) in cash and cash equivalents	219,124	38,370	(4,991)
Cash and cash equivalents at beginning of period	288,557	250,187	255,178
Cash and cash equivalents at end of period	$ 507,681	$ 288,557	$ 250,187

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common stock	Common Stock, Capital in excess of par value	Accum. Deficit	Accum. Other Comp. Loss	Non- controlling Interest
Beginning balance (in shares) at Dec. 31, 2021		202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	$ 2,315,399	$ (525,158)	$ (21,625)	$ (16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	156,563			154,969		1,594
Other comprehensive loss	(7,905)				(7,905)
Stock-based compensation (in shares)		933,000
Stock-based compensation	20,089	$ 10	20,079
Stock options exercised (in shares)		1,748,000
Stock options exercised	10,149	$ 17	10,132
Taxes withheld on issuance of stock-based awards	(11,964)		(11,964)
Dividends declared to common stockholders	(61,291)			(61,291)
Repurchase and cancellation of common stock (in shares)		(7,081,000)
Repurchase and cancellation of common stock	(180,142)	$ (71)	(83,948)	(96,123)
Distributions declared and paid to noncontrolling interest	(3,016)					(3,016)
Currency translation adjustments	425					425
Ending balance (in shares) at Dec. 31, 2022		198,466,000
Ending balance at Dec. 31, 2022	1,677,215	$ 1,985	2,249,698	(527,603)	(29,530)	(17,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	318,719			314,238		4,481
Other comprehensive loss	(6,996)				(6,996)
Stock-based compensation (in shares)		648,000
Stock-based compensation	23,749	$ 6	23,743
Stock options exercised (in shares)		986,000
Stock options exercised	6,056	$ 10	6,046
Taxes withheld on issuance of stock-based awards	(9,763)		(9,763)
Dividends declared to common stockholders	(66,871)			(66,871)
Repurchase and cancellation of common stock (in shares)		(8,965,000)
Repurchase and cancellation of common stock	(277,575)	$ (88)	(102,047)	(175,440)
Distributions declared and paid to noncontrolling interest	(3,505)		(766)			(2,739)
Currency translation adjustments	$ 2					2
Ending balance (in shares) at Dec. 31, 2023	191,300,000	191,135,000
Ending balance at Dec. 31, 2023	$ 1,661,031	$ 1,913	2,166,911	(455,676)	(36,526)	(15,591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	327,129			320,266		6,863
Other comprehensive loss	(43,994)				(43,994)
Stock-based compensation (in shares)		815,000
Stock-based compensation	$ 25,770	$ 8	25,762
Stock options exercised (in shares)	378,195	378,000
Stock options exercised	$ 2,278	$ 4	2,274
Taxes withheld on issuance of stock-based awards	(12,561)		(12,561)
Dividends declared to common stockholders	$ (72,545)			(72,545)
Repurchase and cancellation of common stock (in shares)	(1,611,055)	(1,611,000)
Repurchase and cancellation of common stock	$ (49,399)	$ (18)	(18,288)	(31,093)
Distributions declared and paid to noncontrolling interest	(6,494)					(6,494)
Currency translation adjustments	$ (37)					(37)
Ending balance (in shares) at Dec. 31, 2024	190,700,000	190,717,000
Ending balance at Dec. 31, 2024	$ 1,831,178	$ 1,907	$ 2,164,098	$ (239,048)	$ (80,520)	$ (15,259)

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared to common shareholders (in dollars per share)	$ 0.095	$ 0.38	$ 0.34	$ 0.30

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of the Business ChampionX Corporation is a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well. Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires. On June 3, 2020, the Company and Ecolab Inc. (“Ecolab”) completed a Reverse Morris Trust transaction in which we acquired the Chemical Technologies business (the “Ecolab Merger”). At the completion of the Ecolab Merger, the Company changed its name from Apergy Corporation (“Apergy”) to ChampionX Corporation. Merger Agreement On April 2, 2024, ChampionX entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Schlumberger Limited, a Curaçao corporation (“SLB”), Sodium Holdco, Inc., a Delaware corporation and indirect wholly owned subsidiary of SLB, (“Holdco”), and Sodium Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of SLB and Holdco (“Merger Sub”), pursuant to which, and subject to the terms and conditions therein, Merger Sub will be merged with and into ChampionX (the “Merger”, together with the other transactions contemplated by the Merger Agreement, the “Transactions”), with ChampionX surviving the Merger as an indirect wholly owned subsidiary of SLB. Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”) and by virtue of the Merger, each share of common stock, par value $0.01 per share, of ChampionX issued and outstanding immediately prior to the Effective Time (other than any shares of ChampionX common stock held in the treasury of ChampionX or held by SLB, Holdco or any direct or indirect wholly owned subsidiary of SLB, in each case except for any such shares held on behalf of third parties) will be converted, without any action on the part of the holder thereof, into the right to receive 0.735 shares of common stock, par value 0.01 per share, of SLB (“SLB Common Stock”), which shares will be duly authorized and validly issued in accordance with applicable laws (the “Equity Consideration”) and, if applicable, cash in lieu of fractional shares. The Merger Agreement contains certain termination rights for each of ChampionX and SLB. Upon termination of the Merger Agreement under specified circumstances, including the termination by either party if certain Mutual Legal Restraints exist, specified regulatory approvals have not been obtained or if the consummation of the Merger does not occur on or prior to April 2, 2025 (subject to an automatic extension to October 2, 2025 under specified circumstances) and, subject to certain exceptions, the parties will have satisfied the conditions to the merger, SLB would be required to pay ChampionX a termination fee of $326.6 million. During the year ended December 31, 2024, we recorded third party legal and professional fees of $37.8 million in connection with the pending Merger with SLB. These costs are reflected in selling, general and administrative expense within our consolidated statement of income. Basis of Presentation Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany accounts and transactions have been eliminated. Significant Accounting Policies Use of estimates— The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Such estimates include, but are not limited to, net realizable value of inventories; allowance for doubtful accounts; pension and post-retirement plans; future cash flows associated with impairment testing of goodwill; indefinite-lived intangible assets and other long-lived assets; estimates related to income taxes; and estimates related to contingencies. Cash and cash equivalents— Cash equivalents are highly liquid, short-term investments with original maturities of three months or less from their date of purchase. Receivables, net— Accounts receivable are carried at the invoiced amounts, less an allowance for doubtful accounts, and generally do not bear interest. The Company estimates the allowance for doubtful accounts for expected credit losses by analyzing accounts receivable balances through the application of historical write-off and collection trend rates, as well as current economic and market conditions. Specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Account balances are written off against the allowance when it is determined the receivable will not be recovered. Inventories, net— Inventories are stated at the lower of cost or net realizable value. The majority of our inventory costs are determined on the first-in, first-out (FIFO) basis. As of December 31, 2024 and 2023, approximately 28% and 28%, respectively, of our total net inventories were accounted for using the last-in, first-out (LIFO) basis. Under the LIFO method, the cost assigned to items sold is based on the cost of the most recent items purchased. As a result, the costs of the first items purchased remain in inventory and are used to value ending inventory. Inventories, net consisted of the following: December 31, (in thousands) 2024 2023 Raw materials $ 131,605 $ 137,402 Work in progress 24,431 16,915 Finished goods 420,282 445,437 576,318 599,754 Inventory reserve (27,997) (29,081) LIFO adjustments (1) (51,490) (49,124) Inventories, net $ 496,831 $ 521,549 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value. Property, plant and equipment, net— Property, plant and equipment is recorded at cost, or fair value for those assets acquired in a business combination. Depreciation is applied on the straight-line basis over the estimated useful lives of our assets as follows: buildings and improvements 5 to 40 years; machinery and equipment 1 to 20 years; and software 3 to 7 years. Expenditures for maintenance and repairs are expensed as incurred. Gains and losses are realized upon the sale or disposition of assets and are recorded in other expense (income), net on our consolidated statements of income. Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate the carrying value of the long-lived asset may not be recoverable. The carrying value of a long-lived asset is not recoverable to the extent it exceeds the sum of undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that an impairment loss has occurred, the impairment loss is measured as the amount by which the carrying value of the long-lived asset exceeds its fair value. Goodwill and intangible assets, net— We review goodwill for impairment annually or more frequently if events or changes in circumstances indicate that the carrying amount of such goodwill allocated to reporting units may exceed their fair value. We initially assess goodwill for impairment based on qualitative factors to determine whether it is necessary to perform a goodwill impairment test. When performing the quantitative assessment, we estimate fair value of our reporting units using an income approach. Our income-based valuation method determines the present value of estimated future cash flows to estimate the fair value of a reporting unit, which requires the use of significant unobservable inputs, and represents a Level 3 fair value measurement. Significant assumptions used in estimating our reporting unit fair values include discount rate, revenue growth rates, future operating margins, future capital expenditures, changes in working capital requirements and terminal growth rates. If the carrying amount exceeds the fair value, an impairment charge will be recognized in an amount equal to the excess; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Our finite-lived acquired intangible assets are amortized on a straight-line basis over their estimated useful lives, which generally range from 3 to 15 years. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of the intangible asset may not be recoverable. The carrying amount of an intangible asset is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that an impairment loss has occurred, the loss is measured as the amount by which the carrying amount of the intangible asset exceeds its fair value. We have two intangible assets with an indefinite life which are tested annually for impairment. See Note 7—Goodwill and Intangible Assets for additional information related to our impairment analysis. Revenue Recognition— Revenue is recognized upon the transfer of control of the related goods and services to the customer. The majority of our revenue is generated through the manufacture and sale of a broad range of specialized products and components, with revenue recognized upon transfer of control, which typically occurs as title and risk of loss transfers. We account for shipping and handling activities performed after control of a good has been transferred to the customer as a contract fulfillment cost rather than a separate performance obligation. Revenue arrangements with customers may require delivery, installation, testing, or other acceptance provisions to be satisfied before revenue is recognized. Service revenue is recognized as the services are performed. Estimates are used to determine the amount of variable consideration in contracts, as well as the determination of the standalone selling price among separate performance obligations. No material variable consideration has been identified within our contracts. Lessor accounting —Our lease arrangements generally allow customers to rent equipment on a daily basis with no stated end date. Customers may return the equipment at any point subsequent to the lease commencement date without penalty. We account for these arrangements as a daily renewal option beginning on the lease commencement date, with the lease term determined as the period in which it is reasonably certain the option will be exercised. Based on our assessment of the lease classification criteria, our lease arrangements have been classified as operating leases. Our lease arrangements generally include lease and non-lease components for which revenue is recognized based on each component’s standalone selling price. Lease revenue is recognized on a straight-line basis over the term of the lease and is included in lease and other revenue in the consolidated statements of income. Non-lease components related to our lease arrangements, such as installation, monitoring and field service support, are recognized in accordance with our revenue recognition accounting policy. Assets in our lease program are reported in property, plant, and equipment, net on our consolidated balance sheets and are depreciated over their estimated useful lives. Certain contracts allow for leased equipment damaged in operation to be charged to the customer. Charges for damaged leased equipment is recorded as product revenue and the remaining net book value of the leased asset is expensed as costs of goods and services in the consolidated statements of income. Lessee accounting —Lease liabilities are measured at the lease commencement date and are based on the present value of remaining payments contractually required under the contract. Payments that are variable in nature are excluded from the measurement of our lease liabilities and are recorded as an expense as incurred. Options to renew or extend a lease are included in the measurement of our lease liabilities only when it is reasonably certain that we will exercise these rights. In estimating the present value of our lease liabilities, payments are discounted at our incremental borrowing rate (“IBR”), which we apply utilizing a portfolio approach. We utilize information publicly available from companies within our industry with similar credit profiles to construct a company-specific yield curve in order to estimate the rate of interest we would pay to borrow at various lease terms. At lease commencement, we recognize a lease right-of-use asset equal to our lease liability, adjusted for lease payments paid to the lessor prior to the lease commencement date, and any initial direct costs incurred. Operating lease expense is recorded on a straight-line basis over the lease term. For finance leases, we amortize our right-of-use assets on a straight-line basis over the shorter of the asset’s useful life or the lease term. Additionally, interest expense is recognized each period related to the accretion of our lease liabilities over their respective lease terms. Stock-based compensation— The cost of stock-based awards is measured at the grant date and is based on the fair value of the award. The value of the portion of the award that is expected to ultimately vest is recognized as expense on a straight-line basis, generally over the explicit service period and is included in selling, general and administrative expense in our consolidated statements of income. Forfeitures are accounted for as they occur, but are not material to the financial statements. Expense for awards granted to retirement-eligible employees is recorded over the period from the date of grant through the date the employee first becomes eligible to retire and is no longer required to provide service. Research and development costs— Research and development costs are expensed as incurred and amounted to $56.3 million, $53.3 million, and $45.1 million for the years ended December 31, 2024, 2023, and 2022, respectively, and are included in selling, general and administrative expense in the consolidated statements of income. Income Taxes— Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. We record valuation allowances related to our deferred tax assets when we determine it is more likely than not the benefits will not be realized. Interest and penalties related to unrecognized tax benefits are recorded as a component of our provision for income taxes. We have recorded a deferred tax liability of approximately $19.7 million for foreign withholding taxes on our undistributed foreign earnings from jurisdictions which impose such taxes. The Global Intangible Low-Taxed Income (“GILTI”) provisions of the Tax Reform Act require us to include in our U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. We have elected to account for GILTI tax in the period in which it is incurred. Earnings per share (“EPS”)— Basic EPS is computed using the weighted-average number of common shares outstanding during the year. We use the treasury stock method to compute diluted EPS which gives effect to the potential dilution of earnings that could have occurred if additional shares were issued for awards granted under our incentive compensation and stock plan. The treasury stock method assumes proceeds that would be obtained upon exercise of awards granted under our incentive compensation and stock plan are used to purchase outstanding common stock at the average market price during the period. Investments in Affiliated Companies— Investments in companies in which ChampionX does not have a controlling financial interest, but over which it has significant influence, are accounted for using the equity method and reported within other non-current assets in our consolidated balance sheets. ChampionX’s share of the after-tax earnings of equity method investees is included within other expense (income), net in our consolidated statements of income. Fair value measurements— We record our financial assets and financial liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date (an exit price). In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy: • Level 1 — Unadjusted quoted prices in active markets for identical assets and liabilities. • Level 2 — Observable inputs other than quoted prices included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. • Level 3 — Unobservable inputs reflecting management’s own assumptions about the assumptions market participants would use in pricing the asset or liability. Derivative financial instruments— The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt, to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. See Note 17—Derivatives and Hedging Transactions for further information. Foreign currency—

NEW ACCOUNTING STANDARDS

NEW ACCOUNTING STANDARDS	12 Months Ended
	Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]
NEW ACCOUNTING STANDARDS	NEW ACCOUNTING STANDARDS New Accounting Standards Issued In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2024-03, “Disaggregation of Income Statement Expenses (DISE)” which requires a public business entity to disclose the nature of certain expenses within the footnotes of the financial statements, including purchases of inventory, employee compensation, depreciation, intangible asset amortization and the total amount of selling expenses. The guidance is effective for annual periods beginning after December 15, 2026, with early adoption permitted. In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2023-09, “Improvements to Income Tax Disclosure” which requires a public business entity to disclose disaggregated information about a reporting entity’s effective tax rate reconciliation, using both percentages and reporting currency amounts for specific standardized categories. Separate disclosures will be required for any reconciling items that are equal to or greater than a specified quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. Accounting Standards Adopted In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures” which requires a public business entity to disclose its significant segment expense categories and amounts for each reportable segment. A significant segment expense is an expense that is significant to the segment, regularly provided to or easily computes from information regularly provided to the Chief operating decision maker (CODM), and included in the reported measure of segment profit or loss. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 3—Segment Information for significant expense categories and amounts for each reportable segment.

SEGMENT INFORMATION

SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION Our reportable segments comprise the structure used by our Chief Executive Officer who is also our Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. For all of the segments, the CODM uses segment operating profit in the annual budgeting and monthly forecasting process and as a basis for making decisions about allocating capital and other resources to each segment. Further, cost of goods and services, selling, general and administrative expense, accounts receivable and inventory are regularly provided to the CODM as part of the monthly review of segment financial results to monitor productivity, overhead and working capital. Our reporting segments are: • Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues. • Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, Windrock, Scientific Aviation, ChampionX Emissions Technologies, Artificial Lift Performance and RMSpumptools. • Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand. • Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs in the oil and natural gas industry. We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Although Reservoir Chemical Technologies is not required to be disclosed separately as a reportable segment based on materiality, management believes the additional information may contribute to a better understanding of the business. Other business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments. Segment revenue and segment operating profit Year Ended December 31, 2024 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue 2,288,886 1,042,369 211,828 94,296 3,637,379 (3,396) 3,633,983 Cost of goods and services 1,548,993 701,924 124,349 69,921 2,445,187 94 2,445,281 Selling, general and administrative expense 373,191 218,290 38,859 12,227 642,567 78,065 720,632 Other segment items 2,655 (1,685) (29,849) 70 (28,809) (1,864) (30,673) Segment operating profit 364,047 123,840 78,469 12,078 578,434 (79,691) 498,743 Interest expense, net — — — — — 55,868 55,868 Income before income taxes 364,047 123,840 78,469 12,078 578,434 (135,559) 442,875 Year Ended December 31, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue 2,404,377 1,003,146 215,721 96,154 3,719,398 38,887 3,758,285 Cost of goods and services 1,683,121 692,994 129,104 71,979 2,577,198 41,448 2,618,646 Selling, general and administrative expense 345,000 193,349 41,102 13,484 592,935 40,097 633,032 Other segment items 26,040 (1,606) 34 150 24,618 3,603 28,221 Segment operating profit 350,216 118,409 45,481 10,541 524,647 (46,261) 478,386 Interest expense, net — — — — — 54,562 54,562 Income before income taxes 350,216 118,409 45,481 10,541 524,647 (100,823) 423,824 Year Ended December 31, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue $ 2,347,526 $ 954,646 $ 229,479 $ 145,197 $ 3,676,848 $ 129,100 $ 3,805,948 Cost of goods and services 1,786,227 671,485 135,546 177,643 2,770,901 136,383 2,907,284 Selling, general and administrative expense 302,577 191,817 39,438 17,628 551,460 40,822 592,282 Other segment items 18,786 2,211 (17) 40,138 61,118 3,254 64,372 Segment operating profit 239,936 89,133 54,512 (90,212) 293,369 (51,359) 242,010 Interest expense, net — — — — — 45,204 45,204 Income before income taxes $ 239,936 $ 89,133 $ 54,512 $ (90,212) $ 293,369 $ (96,563) $ 196,806 ____________________ (1) Corporate and other includes costs not directly attributable or allocated to our reportable segments such as overhead and other costs pertaining to corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from June 3, 2020, the date of the Ecolab Merger in which we acquired the Chemical Technologies business, through June 30, 2023. Beginning, July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment. Geographic information December 31, (in thousands) 2024 2023 Property, plant, and equipment, net: United States $ 522,850 $ 522,640 Singapore 72,085 80,526 Canada 64,649 69,974 Other Countries 95,838 100,412 Total property, plant, and equipment, net $ 755,422 $ 773,552 See Note 5—Revenue for information related to revenue by geography and end markets. Other business segment information Segment Assets (in thousands) 2024 2023 2022 Chemical Technologies (1) $ 535,033 $ 647,389 $ 718,882 Production & Automation Technologies 375,492 358,372 371,087 Drilling Technologies 49,998 48,700 52,552 Total segment assets (2) 960,523 1,054,461 1,142,521 Other current assets 603,374 370,956 $ 356,060 Noncurrent assets 1,906,355 1,816,285 1,888,902 Total assets $ 3,470,252 $ 3,241,702 $ 3,387,483 _______________________ (1) Our Chemical Technologies business has an integrated supply chain function that serves the Production Chemical Technologies and Reservoir Chemical Technologies reportable segments. As such, segment assets by each reportable segment has not been provided and is not available, since the Company does not produce or utilize such information. (2) The significant asset categories that is regularly provided to the chief operating decision maker (“CODM”) includes total accounts receivable and inventory. The amounts align with segment level information provided in the CODM package. Capital Expenditures (in thousands) 2024 2023 2022 Chemical Technologies (1) $ 58,805 $ 49,485 $ 41,782 Production & Automation Technologies 76,424 86,029 56,363 Drilling Technologies 5,198 4,700 3,732 Corporate and other 883 2,110 931 Total $ 141,310 $ 142,324 $ 102,808 _______________________ (1) Our Chemical Technologies business has an integrated supply chain function that serves the Production Chemical Technologies and Reservoir Chemical Technologies reportable segments. As such, capital expenditure information by each reportable segment has not been provided and is not available, since the Company does not produce or utilize such information. Depreciation & Amortization (in thousands) 2024 2023 2022 Production Chemical Technologies $ 106,394 $ 105,058 $ 91,875 Production & Automation Technologies 125,884 109,017 103,592 Drilling Technologies 5,465 6,192 6,639 Reservoir Chemical Technologies 6,196 6,471 14,662 Corporate and other 1,886 9,198 25,112 Total $ 245,825 $ 235,936 $ 241,880

ACQUISITIONS, DIVESTITURES AND

ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK	ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK Acquisitions OTS Consulting Services LLP On January 5, 2024 we completed an agreement with OTS Consulting Services LLP (“OTS”), a privately held engineering services company based in Pune, India, to acquire the assets and liabilities relating solely to the services performed by OTS for us prior to the acquisition. OTS specializes in digital transformation and advanced IT solutions. The acquired assets and liabilities are included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid $8.7 million, inclusive of working capital adjustments. As part of our purchase price allocation, we recorded goodwill of $6.4 million. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. Artificial Lift Performance Limited On February 26, 2024, we acquired Artificial Lift Performance Limited (“ALP”), a provider of advanced analytics solutions for enhancing oil and gas production performance based in Edinburgh, Scotland. These assets and liabilities have been included in our Production & Automation Technologies segment. Under the terms of the agreements, we paid an initial amount of $13.4 million, with an additional $1.7 million payable on the first anniversary of the closing date, and a maximum earn out potential of $3.0 million over the next two years. As part of our purchase price allocation, we recorded definite-lived intangible assets of $10.4 million which consists of assumed software, trademarks and customer relationships and recorded $9.4 million of goodwill, which is inclusive of purchase price accounting adjustments. In addition, we assumed liabilities of $7.6 million, which includes the holdback payment and earn-out consideration. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. RMSpumptools Limited On July 8, 2024, we completed the acquisition of RMSpumptools Limited, a UK-based company that designs and manufactures highly engineered mechanical and electrical solutions for complex artificial lift applications. The purpose of the acquisition is to create growth opportunities in the artificial lift business internationally and this business line will be included in our Production & Automation Technologies segment. We paid $106.1 million, and as part of our purchase price allocation, we recorded definite-lived intangible assets of $53.0 million, which consists of customer relationships, unpatented technology and trade names and recorded $45.0 million of goodwill, which is inclusive of purchase price accounting adjustments. In addition, we assumed liabilities of $29.0 million , which includes a $13.8 million deferred tax liability. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. The following table provides the initial allocation of the purchase price as of the acquisition date. (in thousands) Cash and cash equivalents $ 4,262 Receivables 14,466 Inventories 15,168 Prepaid expenses and other current assets 484 Property, plant, and equipment 1,335 Identifiable intangible assets 53,000 Operating leases right-of-use asset 1,162 Other noncurrent assets 192 Total identifiable assets acquired 90,069 Accounts payable 6,342 Accrued compensation and employee benefits 3,261 Accrued expenses and other current liabilities 4,296 Deferred income taxes 13,849 Operating lease liabilities 1,267 Total liabilities assumed 29,015 Net identifiable assets acquired 61,054 Goodwill 45,005 Total net assets acquired $ 106,059 The purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based on their preliminary fair value estimates as of the acquisition date. The measurements of assets acquired and liabilities assumed are based on inputs that are not observable in the market and thus represent Level 3 inputs. The excess of the purchase price over such fair values was recorded as goodwill. Divestitures Russia Due to the deteriorating business conditions in Russia following the Ukraine invasion and the resultant sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale during the second quarter of 2022 and we measured the carrying value of the disposal group to the lower of its carrying value or fair value less costs to sell, resulting in net charges of $16.5 million for the year ended December 31, 2022. We assess the fair value of the CT Russia Business (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Due to the continued deterioration of the business environment, increasing trade regulations and sanctions and Russia’s imposition of an exit tax on divestments to facilitate exit from in-country operations, we assessed the fair value less cost to sell the business as of March 31, 2023 to be zero, resulting in a $13.0 million pre-tax impairment expense recorded during the three months ended March 31, 2023, which is reflected in loss (gain) on disposal group and sale-leaseback transaction within our consolidated statements of income. There were no charges during the year ended December 31, 2024. Sale-Leaseback Orem, Utah On March 29, 2024, we entered into a sale-leaseback agreement with an unrelated party involving three buildings in Orem, Utah. Under the arrangement, the property (land and buildings) with a net book value of $14.1 million was sold for $45.5 million and leased back under a twenty year lease agreement. We received cash of $44.3 million, net of closing costs and other fees related to the sale of the property. The lease provides for annual base payments of $3.3 million and expires in March 2044 with an option to extend the term of the lease for one additional seven-year period. The transaction qualifies as a sale-leaseback, and as a result, we recorded a $29.8 million net gain on sale in our Drilling Technologies segment .

REVENUE

REVENUE	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable. In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our consolidated balance sheets. Revenue disaggregated by geography was as follows: Year Ended December 31, 2024 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 1,024,847 $ 781,260 $ 166,843 $ 50,050 $ — $ 2,023,000 Latin America 307,590 31,792 221 13,141 — 352,744 Middle East & Africa 353,240 78,471 7,565 22,768 (3,396) 458,648 Canada 315,696 68,020 17,815 2,174 — 403,705 Europe 199,727 18,612 15,264 4,370 — 237,973 Asia-Pacific 66,805 10,759 4,120 1,756 — 83,440 Australia 20,981 53,455 — 37 — 74,473 Other — — — — — — Total revenue $ 2,288,886 $ 1,042,369 $ 211,828 $ 94,296 $ (3,396) $ 3,633,983 Year Ended December 31, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 983,542 $ 763,103 $ 163,776 $ 49,171 $ 20,659 $ 1,980,251 Latin America 522,372 22,727 — 13,182 1,720 560,001 Middle East & Africa 325,142 65,396 10,471 26,553 (1,170) 426,392 Canada 296,001 73,806 14,326 1,423 18 385,574 Europe 196,533 17,641 23,401 2,803 5,121 245,499 Asia-Pacific 48,718 13,556 3,745 2,444 12,539 81,002 Australia 22,739 46,917 — 15 — 69,671 Other 9,330 — 2 563 — 9,895 Total revenue $ 2,404,377 $ 1,003,146 $ 215,721 $ 96,154 $ 38,887 $ 3,758,285 Year Ended December 31, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 851,057 $ 738,178 $ 180,912 $ 88,108 $ 76,461 $ 1,934,716 Latin America 594,737 21,756 7 13,887 3,100 633,487 Middle East & Africa 307,154 66,918 6,628 26,876 2,314 409,890 Canada 296,623 73,561 14,529 1,933 116 386,762 Europe 194,034 13,655 20,911 3,439 13,936 245,975 Asia-Pacific 35,536 6,170 6,434 3,115 33,173 84,428 Australia 21,866 34,318 33 299 — 56,516 Other 46,519 90 25 7,540 — 54,174 Total revenue $ 2,347,526 $ 954,646 $ 229,479 $ 145,197 $ 129,100 $ 3,805,948 _______________________ (1) The sales related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from the date of the Ecolab Merger through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment. Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user. Performance Obligations Some of our contracts have a single performance obligation which represents, in most cases, the equipment or product sold to the customer. Some contracts include multiple performance obligations, often satisfied at or near the same time, such as a product and the related installation and/or maintenance services. For contracts with multiple performance obligations, we allocate the transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. We typically use observable prices to determine the stand-alone selling price of a performance obligation. Within our Production Chemical Technologies and Reservoir Chemical Technologies segments, revenue recognized from the sale of products is recognized at the point in time when the obligations in the contract with the customer are satisfied, which generally occurs with the delivery of the product. Within our Production & Automation Technologies and Drilling Technologies reportable segments, substantially all of our performance obligations are recognized at a point in time and are primarily related to product revenue derived from the sale of drilling and production equipment. Revenue is recognized when control transfers to the customer upon shipment or completion of installation, testing, or certification as required under the contract. Within our ESP leased asset program, when stipulated in the contract, equipment damaged in operation is charged to the customer and recognized as product revenue. Service and lease revenue are recognized over time when the services are provided to the customer or when the customer receives the benefit of the leased equipment. Remaining performance obligations As of December 31, 2024, we did not have any contracts with an original length of greater than a year from which revenue is expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied). Contract Balances The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: December 31, (in thousands) 2024 2023 Contract assets $ — $ — Contract liabilities 16,517 27,406 Contract liabilities relate to billings or consideration received in advance of performance (obligation to transfer goods or services to a customer) under the contract. Contract liabilities are recognized as revenue when the performance obligation has been performed, which primarily occurs during the subsequent quarter. Current contract liabilities are recorded in accrued expenses and other current liabilities on our consolidated balance sheets.

PROPERTY, PLANT AND EQUIPMENT,

PROPERTY, PLANT AND EQUIPMENT, NET	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT, NET	PROPERTY, PLANT AND EQUIPMENT, NET Property, plant and equipment, net consisted of the following: December 31, (in thousands) 2024 2023 Land and land improvements $ 120,305 $ 126,151 Buildings and improvements 286,593 311,436 Software 66,540 60,945 Machinery, equipment and other 1,131,449 1,056,387 1,604,887 1,554,919 Accumulated depreciation (849,465) (781,367) Property, plant and equipment, net $ 755,422 $ 773,552 Depreciation expense was $190.9 million, $174.0 million, and $154.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS Goodwill The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2022 $ 367,084 $ 211,268 $ 101,136 $ — $ 679,488 Foreign currency translation (10,526) 102 — — (10,424) December 31, 2023 356,558 211,370 101,136 — 669,064 Acquisition (1) — 60,754 — — 60,754 Foreign currency translation (8,998) (1,876) — — (10,874) December 31, 2024 $ 347,560 $ 270,248 $ 101,136 $ — $ 718,944 _______________________ (1) See Note 4—Acquisitions, Divestitures and Sale-Leaseback for additional information related to the acquisitions completed during the first and third quarters of 2024. We completed our annual goodwill impairment test as of October 1, 2023 and October 1, 2024 for Production Chemical Technologies, Production & Automation Technologies and Drilling Technologies and concluded that the goodwill related to these reporting units was not impaired. The annual impairment tests did not include Reservoir Chemical Technologies as that reporting unit had no goodwill following a goodwill impairment charge totaling $39.6 million recorded October 1, 2022 to write off the remaining goodwill within that reporting unit. Intangible Assets The components of our definite- and indefinite-lived intangible assets were as follows: December 31, 2024 December 31, 2023 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships (1) $ 324,893 $ 177,831 $ 147,062 $ 583,326 $ 438,181 $ 145,145 Unpatented technologies (1) 173,333 96,984 76,349 142,760 75,224 67,536 Trademarks (1) 31,575 12,335 19,240 59,862 39,564 20,298 Patents (1) 35,722 30,323 5,399 36,438 30,664 5,774 Other 6,980 1,216 5,764 — — — 572,503 318,689 253,814 822,386 583,633 238,753 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 577,303 $ 318,689 $ 258,614 $ 827,186 $ 583,633 $ 243,553 _______________________ (1) See Note 4—Acquisitions, Divestitures and Sale-Leaseback for additional information related to the acquisitions completed during the first and third quarters of 2024. We recorded definite-lived intangible assets of $10.4 million for the acquisition of Artificial Lift Performance and $53.0 million for RMSpumptools. During 2024, we identified all intangible assets that were fully amortized and removed the fully amortized balances from the gross asset and accumulated amortization amounts. This did not have an impact on the consolidated balance sheet or consolidated income statement. Amortization expense related to our intangible assets was $55.0 million, $61.9 million, and $87.3 million for the years ended December 31, 2024, 2023, and 2022, respectively. Estimated future amortization expense related to intangible assets held as of December 31, 2024, is as follows: (in thousands) Estimated Amortization 2025 $ 46,946 2026 46,588 2027 35,480 2028 25,813 2029 22,312

DEBT

DEBT	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
DEBT	DEBT Long-term debt consisted of the following: December 31, (in thousands) 2024 2023 2022 Revolving Credit Facility $ — $ — 2022 Term Loan Facility 612,559 618,762 Total 612,559 618,762 Net unamortized discounts and issuance costs (14,903) (18,276) Total long-term debt 597,656 600,486 Current portion of long-term debt (1) (6,203) (6,203) Long-term debt, less current portion $ 591,453 $ 594,283 _______________________ (1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of December 31, 2024. 2022 Credit Facility On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the prior credit agreement. The Restated Credit Agreement provides for (i) a $625.0 million seven-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700.0 million, of which $100.0 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135.0 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our prior credit agreement, repay and terminate our 2020 Term Loan Facility, and to redeem all outstanding 6.375% Senior Notes due 2026 (the “Notes”). Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The initial amount drawn on the 2022 Revolving Credit Facility has been repaid. As of December 31, 2024, we had no amounts outstanding on the 2022 Revolving Credit Facility. 2022 Term Loan Facility The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which began on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of December 31, 2024. On September 29, 2023, we amended the Restated Credit Agreement to, among other things, reprice the Company’s $620.3 million of existing term loans under the 2022 Term Loan Facility, in connection with which new term loans in the same amount were issued. The new term loans bear interest at a per annum rate of (i) an adjusted SOFR Rate plus 2.75% per annum or (ii) a base rate plus 1.75%. The new term loans may be prepaid at any time without penalty, subject to the payment of customary breakage costs in the case of the SOFR rate loans. All other material terms of the Senior Secured Credit Facility remain unchanged. On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300.0 million notional amount for the first three years, reducing to $150.0 million for years four and five. See Note 16—Fair Value Measurements and Note 17—Derivatives and Hedging Transactions for additional information on interest rate swaps. 2020 Term Loan Facility The 2020 Term Loan Facility was entered into on June 3, 2020, and had an initial commitment of $537.0 million. Proceeds were utilized to fund a cash payment of $527.4 million to Ecolab upon the completion of the Ecolab Merger. The remaining balance was repaid June 7, 2022. 2018 Term Loan Facility The 2018 Term Loan Facility had an initial commitment of $415.0 million, which was funded on May 9, 2018. The remaining balance was repaid on June 7, 2022. Senior Notes On May 3, 2018, we completed the offering of $300.0 million in aggregate principal amount of Notes. All remaining Notes were redeemed June 7, 2022. Redemptions and Repurchase In connection with the Restated Credit Agreement, as noted above, we completed the redemption of all the remaining Notes at 103.188% of the principal amount thereof during 2022. We redeemed $92.0 million in aggregate principal amount of the Notes for $95.6 million in cash, including $0.6 million in accrued interest. In connection with these redemptions, we recognized a net loss of approximately $3.9 million for 2022, inclusive of the write off of the remaining unamortized debt financing costs related to the Notes, which is included in other expense (income), net in our consolidated statements of income. As of December 31, 2024, aggregate contractual future principal payments on long-term debt are as follows: (in thousands) Principal Payments ( 1) 2025 $ 6,203 2026 6,203 2027 6,203 2028 6,203 2029 587,747 Total $ 612,559 _______________________ (1) Principal payments included relate to our 2022 Term Loan Facility. See Note 10—Leases for future payments related to finance lease obligations.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters, and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. Lease Commitments See Note 10—Leases for a schedule of future minimum payments on our operating and finance lease arrangements. Guarantees and Indemnifications We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities. As of December 31, 2024 and December 31, 2023, we had $70.3 million and $70.7 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote. Supply Agreements Vendor Supply Agreement We acquired a Vendor Supply Agreement from Ecolab related to the Ecolab Merger, whereby Ecolab made payments in the aggregate of $25.0 million and the Company assumed the receivable for the repayment of this loan. During the second quarter of 2023, the receivable was settled and the net proceeds received were included in cash flows from operating activities for the year ended December 31, 2023. Litigation and Environmental Matters The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. Environmental Matters The Company is currently participating in environmental assessments and remediation at approximately eight locations, the majority of which are in the United States (“U.S.”). Environmental liabilities have been accrued to reflect our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of December 31, 2024 and December 31, 2023, environmental liability accruals related to these locations were $5.7 million and $5.9 million, respectively. Prior to the commencement of our operations as an independent publicly traded company in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma. Initial remedial efforts were undertaken at the time of discovery of the contamination and we have since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”), ODEQ approved our long-term remediation plan, prepared in connection with an engineering and consulting firm engaged for this purpose and we have accrued liabilities of approximately $1.8 million for this remediation plan. We are now in discussion with ODEQ to finalize a consent order and we cannot fully anticipate the timing, outcome or possible impact of further remedial activities that may be required in a final order, financial or otherwise. Liabilities could increase in the future until such time as we ultimately reach agreement with ODEQ on our remediation plan in a final consent order and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of December 31, 2024.

LEASES

LEASES	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
LEASES	LEASES Lessee Accounting We have operating and finance leases for real estate, vehicles, and equipment. Certain of our vehicle leases include residual value guarantees, which have been excluded from the measurement of our lease liabilities as we do not believe it is probable the residual value guarantees will be paid at the end of the lease. Our real estate and vehicle leases generally include options to renew or extend the lease term at our discretion. These options are included in the measurement of our lease liabilities only when it is reasonably certain that we will exercise these rights. Balance sheet presentation —Leases are presented in our consolidated balance sheet as follows: December 31, (in thousands) Balance Sheet Classification 2024 2023 Right-of Use Assets: Finance leases Property, plant, and equipment, net $ 54,025 $ 41,554 Operating leases Operating lease right-of-use assets 100,427 69,561 Total lease right-of-use assets 154,452 111,115 Lease Liabilities: Finance leases - current Accrued expenses and other current liabilities $ 14,688 $ 11,723 Finance leases Other long-term liabilities 41,586 31,202 Operating leases - current Current portion of operating lease liabilities 16,794 23,292 Operating leases Operating lease liabilities 81,340 41,975 Total lease liabilities $ 154,408 $ 108,192 Components of total lease cost —Components of total lease cost were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost: Amortization of right-of-use assets $ 14,946 $ 11,114 Interest on lease liabilities 3,792 2,480 Operating lease cost 32,809 35,163 Short-term and variable lease cost 13,582 18,845 Sublease income (300) — Total lease cost $ 64,829 $ 67,602 Lease term and discount rate —Our weighted-average remaining lease term and weighted-average discount rate for operating and finance leases are as follows: December 31, 2024 2023 Weighted-average remaining lease term (years): Operating lease 12.5 7.1 Finance lease 4.2 4.1 Weighted-average discount rate: Operating lease 7.8 % 6.4 % Finance lease 7.7 % 7.3 % Maturity Analysis —Future minimum payments, as determined in accordance with ASC 842, on our operating and finance leases as of December 31, 2024 are as follows: (in thousands) Operating Finance 2025 $ 23,476 $ 18,099 2026 17,453 15,367 2027 13,625 14,086 2028 9,842 10,324 2029 8,240 4,729 Thereafter 87,179 2,856 Total future minimum lease payments 159,815 65,461 Interest included within lease payments (61,681) (9,187) Total lease liabilities $ 98,134 $ 56,274 Lessor Accounting Lease revenue is primarily generated from our ESP leased asset program within our Production & Automation Technologies segment. An ESP rental unit has components consisting of surface, downhole and cable equipment. The average length of these arrangements generally range from 12 months to 14 months. Lease revenue for our leased asset programs was $103.5 million and $84.2 million for the years ended December 31, 2024 and 2023, respectively. Leased assets —Components of our leased asset program, all of which are included within property, plant, and equipment, net on our consolidated balance sheet, are as follows: (in thousands) Useful life December 31, 2024 Cable equipment 18 months $ 67,945 Downhole equipment 18 months 68,164 Surface equipment 5 years 122,792 Other lease equipment 3 - 5 years 18,459 277,360 Accumulated depreciation (163,531) Leased assets, net $ 113,829 Depreciation expense on our leased assets was $81.5 million and $67.4 million for the year ended December 31, 2024 and 2023, respectively.
LEASES	LEASES Lessee Accounting We have operating and finance leases for real estate, vehicles, and equipment. Certain of our vehicle leases include residual value guarantees, which have been excluded from the measurement of our lease liabilities as we do not believe it is probable the residual value guarantees will be paid at the end of the lease. Our real estate and vehicle leases generally include options to renew or extend the lease term at our discretion. These options are included in the measurement of our lease liabilities only when it is reasonably certain that we will exercise these rights. Balance sheet presentation —Leases are presented in our consolidated balance sheet as follows: December 31, (in thousands) Balance Sheet Classification 2024 2023 Right-of Use Assets: Finance leases Property, plant, and equipment, net $ 54,025 $ 41,554 Operating leases Operating lease right-of-use assets 100,427 69,561 Total lease right-of-use assets 154,452 111,115 Lease Liabilities: Finance leases - current Accrued expenses and other current liabilities $ 14,688 $ 11,723 Finance leases Other long-term liabilities 41,586 31,202 Operating leases - current Current portion of operating lease liabilities 16,794 23,292 Operating leases Operating lease liabilities 81,340 41,975 Total lease liabilities $ 154,408 $ 108,192 Components of total lease cost —Components of total lease cost were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost: Amortization of right-of-use assets $ 14,946 $ 11,114 Interest on lease liabilities 3,792 2,480 Operating lease cost 32,809 35,163 Short-term and variable lease cost 13,582 18,845 Sublease income (300) — Total lease cost $ 64,829 $ 67,602 Lease term and discount rate —Our weighted-average remaining lease term and weighted-average discount rate for operating and finance leases are as follows: December 31, 2024 2023 Weighted-average remaining lease term (years): Operating lease 12.5 7.1 Finance lease 4.2 4.1 Weighted-average discount rate: Operating lease 7.8 % 6.4 % Finance lease 7.7 % 7.3 % Maturity Analysis —Future minimum payments, as determined in accordance with ASC 842, on our operating and finance leases as of December 31, 2024 are as follows: (in thousands) Operating Finance 2025 $ 23,476 $ 18,099 2026 17,453 15,367 2027 13,625 14,086 2028 9,842 10,324 2029 8,240 4,729 Thereafter 87,179 2,856 Total future minimum lease payments 159,815 65,461 Interest included within lease payments (61,681) (9,187) Total lease liabilities $ 98,134 $ 56,274 Lessor Accounting Lease revenue is primarily generated from our ESP leased asset program within our Production & Automation Technologies segment. An ESP rental unit has components consisting of surface, downhole and cable equipment. The average length of these arrangements generally range from 12 months to 14 months. Lease revenue for our leased asset programs was $103.5 million and $84.2 million for the years ended December 31, 2024 and 2023, respectively. Leased assets —Components of our leased asset program, all of which are included within property, plant, and equipment, net on our consolidated balance sheet, are as follows: (in thousands) Useful life December 31, 2024 Cable equipment 18 months $ 67,945 Downhole equipment 18 months 68,164 Surface equipment 5 years 122,792 Other lease equipment 3 - 5 years 18,459 277,360 Accumulated depreciation (163,531) Leased assets, net $ 113,829 Depreciation expense on our leased assets was $81.5 million and $67.4 million for the year ended December 31, 2024 and 2023, respectively.

RESTRUCTURING

RESTRUCTURING	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURING During 2024, management approved restructuring plans within our Production & Automation Technologies segment and Production Chemical Technologies segment to optimize profitability, which includes the exit of certain products, facility closures, and reducing headcount across the organization to support the remaining business. As a result of these plans, we recorded $11.3 million of restructuring expense. All significant actions under the plans were completed during the year ended December 31, 2024. We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during prior periods. During 2023, we recognized net charges of $6.3 million consisting primarily of contract termination costs, inventory obsolescence, and employee severance and related benefits. During 2022, we completed the exit of one of our product lines within the Reservoir Chemical Technologies segment. As a result, we recognized net charges of $68.1 million during 2022, consisting primarily of contract termination costs, employee severance and related benefits, disposals of equipment and warehouse closures, partially offset by gains realized on the sale of facilities. The following table presents the restructuring and other related charges by segment as classified in our consolidated statements of income. Years Ended December 31, (in thousands) 2024 2023 2022 Segment restructuring charges: Production Chemical Technologies $ 6,023 $ 4,662 $ 13,899 Production & Automation Technologies 5,073 770 1,111 Drilling Technologies 234 — — Reservoir Chemical Technologies — 856 47,692 Corporate and other — 6 5,400 Total $ 11,330 $ 6,294 $ 68,102 Statements of Income classification: Cost of goods and services $ 4,998 $ 2,571 $ 47,216 Selling, general and administrative expense 6,332 3,723 20,886 Total $ 11,330 $ 6,294 $ 68,102 Our liability balance for restructuring and other related charges at December 31, 2024 reflects contract termination costs, employee severance and related benefits initiated during the period. The following table details our restructuring accrual activities during the year ended December 31, 2024: (in thousands) Restructuring Accrual Balance December 31, 2023 $ 13,974 Restructuring charges 11,330 Write-offs (3,805) Payments (9,027) December 31, 2024 $ 12,472

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS The Company sponsors several pension and post-employment benefit plans in the U.S. and internationally, of which, approximately half of such plans are frozen to new participants. We recognized a $0.8 million and $0.5 million net actuarial loss, and gains in the amount of $2.9 million during the years ended December 31, 2024, 2023, and 2022, respectively. The actuarial gains and losses are reflected in our consolidated statements of comprehensive income, net of tax. The net unfunded liability of the plans as of December 31, 2024 and 2023 was approximately $8.9 million and $9.3 million, respectively, and is included in other long-term liabilities within our consolidated balance sheets. The net periodic benefit expense was $1.1 million, $0.9 million, and $1.3 million for the years ended December 31, 2024, 2023, and 2022, respectively.

EQUITY AND CASH INCENTIVE PROGR

EQUITY AND CASH INCENTIVE PROGRAMS	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
EQUITY AND CASH INCENTIVE PROGRAMS	EQUITY AND CASH INCENTIVE PROGRAMS Our Board of Directors (“Board”) adopted the 2018 Equity and Cash Incentive Plan (“2018 Plan”). The 2018 Plan was amended and restated in 2020 to increase the shares of common stock reserved for issuance under the 2018 Plan to 18.2 million, and in 2021 to increase the shares of common stock reserved for issuance to 31.4 million, in each case subject to customary adjustments arising from stock splits and other similar changes, along with other amendments. The 2018 Plan authorizes the grant of stock options, stock-settled stock appreciation rights (“SARs”), restricted stock awards, restricted stock units, performance share awards, cash performance awards, directors’ shares and deferred stock units. The ChampionX Compensation Committee determines the exercise price for options and the base price of SARs, which may not be less than the fair value of ChampionX common stock on the date of grant. Generally, stock options or SARs vest after 3 years of service and expire at the end of 10 years. Performance share awards vest if ChampionX achieves certain pre-established performance targets based on specified performance criteria over a performance period of not less than 3 years. Stock-based compensation expense is reported within selling, general and administrative expense in the consolidated statements of income. Stock-based compensation expense relating to all stock-based incentive plans was as follows: Years Ended December 31, 2024 2023 2022 Stock-based compensation expense $ 25,770 $ 23,749 $ 20,089 Tax benefit (5,788) (5,310) (4,492) Stock-based compensation expense, net of tax $ 19,982 $ 18,439 $ 15,597 SARs We did not issue SARs during 2024, 2023 or 2022. A summary of activity relating to SARs outstanding for the year ended December 31, 2024, is as follows: SARs Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2024 235,125 $ 31.89 Forfeited / expired (19,422) 35.53 Exercised (10,834) 33.22 Outstanding at December 31, 2024 204,869 $ 31.47 1.6 $ 117 Exercisable at December 31, 2024 204,869 $ 31.47 1.6 $ 117 There is no unrecognized compensation expense related to SARs, as all SARs are exercisable as of December 31, 2024. Other information regarding the exercise of SARs is presented below: (in thousands) 2024 2023 2022 SARs: Fair value of SARs that became exercisable $ — $ — $ — Aggregate intrinsic value of SARs exercised 37 169 634 Performance Share Units We granted 271,190, 244,120, and 347,920 performance share awards subject to market vesting conditions during 2024, 2023, and 2022, respectively, under the 2018 Plan. Performance share awards are split between those with a performance condition related to ChampionX’s performance related to established internal metrics, and those with a market condition related to certain pre-established performance targets based on specified performance criteria, with all such performance share awards being subject to vest if certain pre-established targets are achieved over a performance period of not less than 3 years. A summary of activity for performance share awards under the 2018 Plan for the year ended December 31, 2024, is as follows: Shares Weighted-Average Unvested at January 1, 2024 901,661 $ 26.04 Granted 271,190 32.65 Forfeited (4,310) 28.54 Vested (511,602) 21.99 Performance adjustment (1) 150,319 21.97 Unvested at December 31, 2024 807,258 $ 29.60 ______________________ (1) Represents the additional shares that were issued to participants upon vesting of the awards due to the performance factor being exceeded for the three-year performance period. Unrecognized compensation expense related to unvested performance share awards as of December 31, 2024, was $9.9 million, which will be recognized over a weighted average period of 1.7 years. Restricted Stock, Restricted Stock Units, Directors’ Shares and Deferred Stock Units Restricted stock and restricted stock units may be granted at no cost to certain officers and key employees. Restricted stock and restricted stock units generally vest over a three Directors’ shares are granted at no cost to non-employee directors and deferred stock units are recorded for non-employee directors who elect to defer receipt of their directors’ shares to a later date. A summary of activity for restricted stock, restricted stock units, directors’ shares and deferred stock units for the year ended December 31, 2024, is as follows: Shares (1) Weighted-Average Unvested at January 1, 2024 1,537,044 $ 24.37 Granted 644,320 30.14 Forfeited (111,281) 26.99 Vested (644,034) 22.78 Unvested at December 31, 2024 1,426,049 $ 27.44 _______________________ (1) Shares unvested on the dates indicated includes deferred stock units recorded for non-employee directors who elected to defer receipt of directors’ shares awarded to a later date; shares granted includes directors’ shares and deferred stock units awarded in the year; and shares vested includes directors’ shares awarded in the year and deferred stock units recorded in previous years that were issued in accordance with a non-employee director’s deferral election. Unrecognized compensation expense relating to unvested restricted stock units, directors’ shares and deferred stock units as of December 31, 2024, was $20.4 million, which will be recognized over a weighted average period of 0.9 year. Non-Qualified Stock Options We did not grant non-qualified stock options in 2024, 2023 or 2022. All outstanding non-qualified stock options were issued to employees of the Chemical Technologies business upon the closing of the Ecolab Merger as replacement awards for options originally granted to them by Ecolab. A summary of activity for non-qualified stock options for the year ended December 31, 2024 is as follows: Non-Qualified Stock Options Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2024 2,728,376 $ 6.41 Granted — — Forfeited / expired — — Exercised (378,195) 6.00 Outstanding at December 31, 2024 2,350,181 $ 6.47 2.4 $ 48,373 Exercisable at December 31, 2024 2,350,181 $ 6.47 2.4 $ 48,373 We had no unrecognized compensation expense relating to unvested stock options as of December 31, 2024. During the year ended December 31, 2024, the total intrinsic value of stock options exercised was approximately $10.3 million and cash received from stock options exercised was approximately $2.3 million. The cash tax benefit from stock options exercised during the year ended December 31, 2024 was approximately $2.0 million.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Dividends On January 31, 2024, our Board approved an increase of our regular quarterly cash dividend to $0.095 per share of the Company’s common stock. Our fourth quarter cash dividend of $0.095 per share was declared on November 14, 2024, and was paid on January 31, 2025 to shareholders of record on January 3, 2025. As a result, we recorded a dividend payable of $19.0 million on our consolidated balance sheet as of December 31, 2024. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors. Repurchases On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock which was increased to $750 million by the Board on October 24, 2022. On January 31, 2024, our Board authorized a further increase in the aggregate value of shares that may be repurchased under the share repurchase program to $1.5 billion. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During 2024

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Years Ended December 31, (in thousands, except per share data) 2024 2023 2022 Net income attributable to ChampionX $ 320,266 $ 314,238 $ 154,969 Weighted-average number of shares outstanding 190,578 196,083 201,740 Dilutive effect of stock-based compensation 3,065 3,823 5,519 Total shares and dilutive securities 193,643 199,906 207,259 Basic earnings per share attributable to ChampionX $ 1.68 $ 1.60 $ 0.77 Diluted earnings per share attributable to ChampionX $ 1.65 $ 1.57 $ 0.75

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount Measurement Level December 31, (in thousands) 2024 2023 Assets Foreign currency forward contracts Level 2 $ 10,078 $ 6,231 Interest rate swaps Level 2 4,199 5,599 Total $ 14,277 $ 11,830 Liabilities Foreign currency forward contracts Level 2 $ 13,430 $ 5,354 Interest rate swaps Level 2 13 — Total $ 13,443 $ 5,354 The carrying value of foreign currency forward contracts is at fair value, which is determined based on foreign currency exchange rates as of the balance sheet date and is classified within Level 2. For purposes of fair value disclosure above, derivative values are presented gross. See Note 17—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives. The fair value of our term loan facility is based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of our revolving line of credit approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2). The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: December 31, 2024 December 31, 2023 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ — $ — $ — $ — 2022 Term Loan Facility $ 612,559 $ 613,324 $ 618,762 $ 623,402 Impairment of Goodwill and Long-lived Assets We consider the inputs for our long-lived asset and goodwill impairment calculations to be Level 3 inputs in the fair value hierarchy. See Note 7—Goodwill and Intangible Assets for additional information. Credit Risk By their nature, financial instruments involve risk, including credit risk, for non-performance by counterparties. Financial instruments that potentially subject us to credit risk primarily consist of trade receivables. See Note 1—Basis of Presentation and Summary of Significant Accounting Policies for additional information on the mitigation of credit risk.

DERIVATIVES AND HEDGING TRANSAC

DERIVATIVES AND HEDGING TRANSACTIONS	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES AND HEDGING TRANSACTIONS	DERIVATIVES AND HEDGING TRANSACTIONS The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts’ hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships. The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary. Derivative Positions Summary Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the consolidated balance sheet. The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the consolidated balance sheet. Derivative Assets Derivative Liabilities December 31, December 31, (in thousands) 2024 2023 2024 2023 Prepaid expenses and other current assets $ 12,455 $ 11,004 $ — $ — Other non-current assets 1,822 826 — — Accrued expenses and other current liabilities — — 13,443 5,354 Other long-term liabilities — — — — $ 14,277 $ 11,830 $ 13,443 $ 5,354 The following table summarizes the notional values of the Company’s outstanding derivatives: December 31, (in thousands) 2024 2023 Notional value of foreign currency forward contracts and interest rate swaps $ 941,784 $ 892,711 Cash Flow Hedges The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to business combinations and inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the consolidated statements of income as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the consolidated statements of income as the underlying exposure being hedged. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Any unrealized gain or loss at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt. Derivatives Not Designated as Hedging Instruments The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities. Effect of Derivative Instruments on Income The loss (gain) on all derivative instruments recognized is summarized below: Years Ended December 31, (in thousands) 2024 2023 2022 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (1,023) $ (2,571) $ (1,665) Interest expense (6,399) (5,034) 549 Loss on derivatives not designated as hedging instruments: Foreign currency transaction losses, net 5,058 1,195 7,147 Total loss (gain) on derivative instruments $ (2,364) $ (6,410) $ 6,031

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Components of income before income taxes —Domestic and foreign components of income before income taxes were as follows: Years Ended December 31, (in thousands) 2024 2023 2022 Domestic $ 243,620 $ 304,725 $ 58,141 Foreign 199,255 119,099 138,665 Income before income taxes $ 442,875 $ 423,824 $ 196,806 Provision for (benefit from) income taxes —The provision for (benefit from) income taxes consisted of: Years Ended December 31, (in thousands) 2024 2023 2022 Current: U.S. federal $ 76,037 $ 74,022 $ 49,997 State and local 8,534 9,234 11,147 Foreign 54,048 44,121 24,381 Total current 138,619 127,377 85,525 Deferred: U.S. federal (22,880) (17,219) (35,207) State and local (1,020) (3,198) (4,900) Foreign 1,027 (1,855) (5,175) Total deferred (22,873) (22,272) (45,282) Provision for income taxes $ 115,746 $ 105,105 $ 40,243 Effective income tax rate reconciliation —The effective income tax rate was different from the statutory U.S. federal income tax rate due to the following: Years Ended December 31, 2024 2023 2022 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Net difference resulting from: State and local taxes, net of federal income tax benefit 0.9 1.1 0.6 Foreign withholding tax 4.2 4.0 5.7 Foreign derived intangible income (1.0) (1.9) (1.0) Foreign operations tax effect (1.4) 2.1 2.8 Research and experimentation tax credits (1.3) (1.3) (1.5) Foreign tax credit (1.2) (3.9) (4.5) Nondeductible expenses — 0.2 0.5 Branch income 1.5 1.2 3.5 Tax return to accrual adjustments (0.3) (1.6) (2.1) State deferred taxes 0.2 (0.2) (1.0) Goodwill impairment — — 1.8 Foreign inclusions (including global intangible low-taxed income) 0.5 4.3 3.5 Change in valuation allowance 2.8 0.8 (7.3) Stock compensation (1.9) (2.1) (3.6) Nondeductible officer compensation 0.9 0.7 0.8 Other 1.2 0.4 1.2 Effective income tax rate 26.1 % 24.8 % 20.4 % Deferred tax assets and liabilities —Significant components of deferred tax assets and liabilities were as follows: December 31, (in thousands) 2024 2023 Deferred tax assets attributable to: Accrued compensation $ 13,654 $ 10,558 Accrued expenses 9,118 6,565 Inventories 3,146 4,674 Net operating loss and other carryforwards 37,928 31,355 Accounts receivable 13,646 13,401 Lease liability 14,404 7,198 Research and Development 41,202 31,324 Other assets 7,167 1,258 Deferred tax assets 140,265 106,333 Valuation allowance (45,992) (33,031) Deferred tax assets, net of valuation allowance $ 94,273 $ 73,302 Deferred tax liabilities attributable to: Inventories $ (1,142) $ (3,462) Intangible assets, including goodwill (51,318) (38,651) Property, plant and equipment (56,072) (65,559) Foreign withholding taxes (19,650) (15,934) Lease asset (15,308) (7,012) Investment in subsidiary (2,724) (1,950) Long-term liabilities (2,653) (3,128) Deferred tax liabilities (148,867) (135,696) Net deferred tax liabilities $ (54,594) $ (62,394) Classified as follows in the consolidated balance sheets: Other non-current assets 7,779 9,103 Deferred income taxes (62,373) (71,497) Net deferred tax liabilities $ (54,594) $ (62,394) Effective Tax Rate. Our effective tax rate was 26.1% for 2024 compared to 24.8% for 2023. The lower effective tax rate for 2023 was primarily due to a significant U.S. return to provision benefit. Net operating loss carryforwards. As of December 31, 2024, our deferred tax asset balance included non-U.S. net operating loss carryforwards of $9.4 million. This entire balance is available to be carried forward; certain non-U.S. carryforwards will expire during the years 2025 through 2030. Foreign tax credit carryforwards. As of December 31, 2024, our deferred tax asset balance included U.S. foreign tax credit carryforwards of $30.6 million. This entire balance is available to be carried forward and will begin to expire during 2029. Valuation allowance. Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. With respect to foreign net operating losses, a significant piece of objective negative evidence evaluated was the cumulative loss incurred in various international jurisdictions over the three-year period ended December 31, 2024. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth. In addition, we analyzed our foreign income classification and determined we would not generate sufficient general limitation income to utilize our general limitation foreign tax credits. Based on this evaluation, as of December 31, 2024, we recorded a valuation allowance of $18.9 million relating to net foreign deferred tax assets (including net operating losses) and $27.1 million relating to foreign tax credits to recognize only the portion of the deferred tax asset that is more likely than not to be realized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased if objective negative evidence in the form of cumulative losses are no longer present and additional weight is given to subjective evidence such as our projections of future growth. In addition, if we increase our general limitation income, we could utilize and thus recognize additional foreign tax credit deferred tax assets. Unrecognized tax benefits. We file federal, state, and local tax returns in the United States as well as foreign tax returns. We are routinely audited by the tax authorities in these jurisdictions, and a number of audits are currently underway. We believe all income tax uncertainties have been properly accounted for as of December 31, 2024. The Company accounts for uncertain tax positions in accordance with guidance in ASC 740, “ Income Taxes (Topic 740) ”, which prescribes the minimum recognition threshold a tax position taken or expected to be taken in a tax return is required to meet before being recognized in the financial statements. The Company is subject to U.S. federal income tax as well as income tax in multiple state jurisdictions. The earliest period the Company is subject to examination of federal income tax returns by the Internal Revenue Service is 2021. The state income tax returns and other state tax filings of the Company are subject to examination by the state taxing authorities for various periods, generally up to four years after they are filed. Undistributed Earnings. As of December 31, 2024, the Company has $19.7 million of deferred tax liabilities primarily associated with withholding taxes on undistributed earnings generated by foreign subsidiaries. The Company continues to assert permanent reinvestment of the remaining undistributed earnings for which deferred taxes have not been provided for as of December 31, 2024. If there are policy changes, the Company would record the applicable taxes in the period of change. No deferred taxes have been provided for withholding taxes and other taxes on the remaining earnings as of December 31, 2024 as computation of the potential deferred tax liability associated with these undistributed earnings and any other basis differences is not practicable. Tax Holidays.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Noncontrolling Interest and Unconsolidated Affiliates For the years ended December 31, 2024, 2023, and 2022, we declared and paid $0.8 million, $1.9 million, and $1.2 million, respectively, of distributions to the noncontrolling interest holders in ChampionX Middle East Services LLC. For the years ended December 31, 2024, 2023, and 2022 we declared and paid distributions of $4.8 million, $0.7 million, and $1.3 million respectively, to the noncontrolling interest holders in Champion Arabia Co. Ltd. and $0.9 million, $0.1 million, and 0.2 million respectively, to the noncontrolling interest holders in Petrochem Performance Products LLC.

ACCOUNTS RECEIVABLE FACILITIES

ACCOUNTS RECEIVABLE FACILITIES	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
ACCOUNTS RECEIVABLE FACILITIES	ACCOUNTS RECEIVABLE FACILITIES On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “JPM Accounts Receivable Facility”), as amended, with JPMorgan Chase Bank, N.A. as the purchaser. The amount available for sale under the JPM Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the JPM Accounts Receivable Facility at any time. On March 28, 2024, we entered into an uncommitted accounts receivable purchase agreement (the “HSBC Accounts Receivable Facility” and, together with the JPM Accounts Receivable Facility, the “Accounts Receivable Facilities”) with HSBC Bank USA, National Association, as the purchaser. The amount available for sale under the HSBC Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of CAD $40.0 million or approximately USD $30.0 million in receivables may be sold and remain unpaid under the HSBC Accounts Receivable Facility at any time. Accounts receivable sold under the JPM Accounts Receivable Facility were $631.1 million for the year ended December 31, 2024. The accounts receivable sold that remained outstanding under the JPM Accounts Receivable Facility as of December 31, 2024 was $84.8 million. Accounts receivable sold under the HSBC Accounts Receivable Facility were $98.2 million for the year ended December 31, 2024. The accounts receivable sold that remained outstanding under the HSBC Accounts Receivable Facility as of December 31, 2024 was $19.4 million. During this period, cash receipts from the purchaser at the time of the sale were classified as operating activities in our consolidated statement of cash flows. The difference between the carrying amount of the accounts receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our consolidated statements of income. The loss on sale of accounts receivable was $6.8 million for the year ended December 31, 2024 and $7.1 million for the year ended December 31, 2023 respectively, under the JPM Accounts Receivable Facility. The loss on sale of accounts receivable was $0.9 million for the year ended December 31, 2024, under the HSBC Accounts Receivable Facility.

SUPPLY CHAIN FINANCE

SUPPLY CHAIN FINANCE	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
SUPPLY CHAIN FINANCE	SUPPLY CHAIN FINANCE We use a supply chain finance program in connection with the purchase of goods, which allows our suppliers to work directly with a third party to provide financing by purchasing their receivables earlier in the payment cycle. We maintain the same contractually agreed upon invoice terms prior to each supplier entering into the program. As of December 31, 2024, and December 31, 2023 we had approximately $30.6 million and $30.8 million, respectively under the program, which is included in accounts payable (in thousands) Supply Chain Finance Payables Outstanding December 31, 2023 $ 30,783 Purchases 186,479 Payments (186,390) Other, including foreign currency translation (288) December 31, 2024 $ 30,584

CASH FLOW INFORMATION

CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
CASH FLOW INFORMATION	CASH FLOW INFORMATION Cash payments for income taxes and cash payments for interest incurred related to our debt are as follows: Years Ended December 31, (in thousands) 2024 2023 2022 Cash information: Cash paid for income taxes $ 78,163 $ 116,677 $ 127,271 Cash paid for interest $ 52,118 $ 57,267 $ 46,781 Net increase (decrease) in accounts payable for capital expenditures $ (7,795) $ 4,321 $ (6,803) Supplemental cash flow information related to our lease liabilities is as follows: Statement of Cash Flows Classification December 31, (in thousands) 2024 2023 Cash paid for amounts included in measurement of lease liabilities: Operating leases (1) Operating $ 32,155 $ 35,297 Finance leases - interest Operating $ 3,792 $ 2,480 Finance leases - principal Financing $ 13,838 $ 9,982 Supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets: Operating leases Non-cash $ 52,265 $ 4,197 Finance leases Non-cash $ 23,034 $ 31,113 _______________________ (1) Cash required by operating leases is reported net of operating lease expense in the operating section of our consolidated statements of cash flows in accrued expenses and other liabilities. Leased Asset Program Our ESP leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the years ended December 31, 2024, 2023, and 2022, we transferred $110.7 million, $105.0 million, and $80.2 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our lease program. Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our consolidated statements of cash flows. During the years ended December 31, 2024, 2023, and 2022, we made cash payments of $46.0 million, $58.2 million, and $39.8 million, respectively, for leased asset program equipment. Argentina Blue Chip Swaps The Central Bank of Argentina maintains currency controls that limit our ability to access U.S. dollars in Argentina and remit cash from our Argentine operations. During the year ended December 31, 2024, we executed certain trades known as Blue Chip Swaps, which effectively results in the use of a parallel U.S. dollar exchange rate to convert available Argentine pesos to U.S. dollars. This parallel rate, which cannot be used as the basis to remeasure our net monetary assets in U.S. dollars under GAAP, was on average 29% higher than Argentina's official exchange when the swaps occurred during the first and second quarter of the year, respectively. The Blue Chip Swap transactions resulted in a $7.1 million pre-tax loss on investment during the year ended December 31, 2024, respectively. These losses are reflected in other expense (income), net, within our consolidated statements of income. We did not enter into any Blue Chip Swaps during the fourth quarter of 2024.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II—Valuation and Qualifying Accounts	Schedule II—Valuation and Qualifying Accounts Allowance for Doubtful Accounts Balance at Beginning of Year Charged to Cost and Expense (1) Accounts Written Off Other Balance at End of Year Year Ended December 31, 2024 $ 5,734 395 (1,094) 83 5,118 Year Ended December 31, 2023 $ 5,506 1,480 (1,244) (8) $ 5,734 Year Ended December 31, 2022 $ 7,662 (927) (869) (360) $ 5,506 _______________________ (1) Net of recoveries on previously reserved or written-off balances. Deferred Tax Valuation Allowance Balance at Beginning of Year Additions Reductions Other (2) Balance at End of Year Year Ended December 31, 2024 $ 33,031 13,135 — (174) $ 45,992 Year Ended December 31, 2023 $ 32,500 472 — 59 $ 33,031 Year Ended December 31, 2022 $ 38,716 — (6,120) (96) $ 32,500 _______________________ (2) Other represents impact of changes in foreign exchange rates. Inventory Reserves (including LIFO) Balance at Beginning of Year Additions Reductions Other Balance at End of Year Year Ended December 31, 2024 $ 78,205 15,199 (13,238) (679) $ 79,487 Year Ended December 31, 2023 $ 87,238 18,974 (27,578) (429) $ 78,205 Year Ended December 31, 2022 $ 78,923 26,306 (16,566) (1,425) $ 87,238

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 320,266	$ 314,238	$ 154,969

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Dec. 31, 2024 shares	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Deric Bryant [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Name & Title Date Adopted Character of Trading Arrangement (1) Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement Duration (2) Other Material Terms Date Terminated Deric Bryant, Chief Operating Officer and President, Chemical Technologies October 28, 2024 Rule 10b5-1 Trading Arrangement Up to 495,489 shares to be sold December 31, 2025 N/A N/A _______________________ (1) Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act (the “Rule”). (2) Each trading arrangement permits transactions through and including the earlier to occur of (i) the completion of all sales of shares subject to the arrangement, (ii) the date listed in the “Duration” column, or (iii) the occurrence of such other termination event as specified in the arrangement. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.
Name	Deric Bryant
Title	Chief Operating Officer and President, Chemical Technologies
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 28,2024
Expiration Date	December 31, 2025
Arrangement Duration	429 days
Aggregate Available	495,489	495,489

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Technology is essential to operating and growing our business, serving our customers, and continuing our digital transformation. ChampionX’s cybersecurity structure and strategic efforts are designed to protect our assets, information, and reputation, as well as the privacy of employee, customer, and supplier data. Cybersecurity represents an important component of our overall approach to enterprise risk management (“ERM”), and ChampionX’s cybersecurity policies, standards, processes and practices are fully integrated into its ERM program. Our Enterprise Risk Committee, which consists of members from executive management, corporate compliance and internal audit, oversees our ERM program. Our Enterprise Risk Committee is responsible for, among other things, aligning risk decisions with the Company’s values, policies and procedures and supports integration of risk assessment and controls into day-to-day business processes, planning and decision making. Our Enterprise Risk Committee has identified cybersecurity as a key enterprise risk. Our Enterprise Risk Committee has delegated to our Senior Vice President and Chief Information Officer (CIO) primary responsibility for assessing and managing our material risks from cybersecurity threats. The CIO has served in various roles in information technology and information security for over 25 years, including serving as vice president of global infrastructure and operations, infrastructure security, access management, cloud security, disaster recovery and change management, and vice president of enterprise business applications, architecture and operations. The CIO holds a master’s degree in technology policy management and a doctorate in information technology management, in addition to serving on multiple advisory boards within academia and industry. The other senior leaders who collaborate with the CIO on reviews of the Company’s IT system and cybersecurity risk environment include a senior director of global IT cybersecurity and a senior director of global infrastructure, each of whom have over 20 years of experience managing risks in various roles, including risks arising from cybersecurity threats. We are committed to deploying recognized cybersecurity systems, methods, and best practices. ChampionX uses the National Institute of Standards & Technology Framework (NIST Framework), a toolkit to make an internal assessment of our cybersecurity capabilities and to develop priorities. We take action to assess and manage our technology and cybersecurity environment and to identify material risks from cybersecurity threats directed at our company and those associated with our use of third-party service providers, including the following: • Enterprise cybersecurity maturity assessments performed periodically by a qualified third-party entity which we use to develop a multi-year strategy, investment, and project roadmap focused on improving and enhancing the Company’s security posture; • An annual cybersecurity tabletop exercise and assessment, facilitated by an independent third party, focused on testing our incident response processes and capabilities; and • Regular cybersecurity assessments of various components of our technology environment to help ensure we continuously improve and strengthen our cybersecurity posture.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Technology is essential to operating and growing our business, serving our customers, and continuing our digital transformation. ChampionX’s cybersecurity structure and strategic efforts are designed to protect our assets, information, and reputation, as well as the privacy of employee, customer, and supplier data. Cybersecurity represents an important component of our overall approach to enterprise risk management (“ERM”), and ChampionX’s cybersecurity policies, standards, processes and practices are fully integrated into its ERM program. Our Enterprise Risk Committee, which consists of members from executive management, corporate compliance and internal audit, oversees our ERM program. Our Enterprise Risk Committee is responsible for, among other things, aligning risk decisions with the Company’s values, policies and procedures and supports integration of risk assessment and controls into day-to-day business processes, planning and decision making. Our Enterprise Risk Committee has identified cybersecurity as a key enterprise risk.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	The Board’s Audit Committee oversees our global cybersecurity risk environment, strategy, and priorities. Our CIO, together with other senior leaders, regularly reviews the Company’s global information technology (IT) system with the Committee, including reports on risks from cybersecurity threats and the Company’s processes to monitor the prevention, detection, mitigation and remediation of cybersecurity incidents. In 2024, this review included the CIO’s assessment of our IT and cybersecurity capabilities and continuous improvement plan. Our CIO’s report to the Audit Committee is provided annually or, if the circumstances warrant, more frequently. In addition, the Board receives periodic reports from the Audit Committee and our CIO relating to risks from cybersecurity threats.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our CIO, together with other senior leaders, regularly reviews the Company’s global information technology (IT) system with the Committee, including reports on risks from cybersecurity threats and the Company’s processes to monitor the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Board’s Audit Committee oversees our global cybersecurity risk environment, strategy, and priorities.
Cybersecurity Risk Role of Management [Text Block]	Our CIO and other senior leaders regularly review the results of the assessments, tabletop exercise, cybersecurity roadmap progress, and monthly operational metrics to stay informed about risks from cybersecurity threats and monitor the prevention, detection, mitigation and remediation of cybersecurity incidents. They report this information to the Audit Committee and ERM Committee as appropriate, together with measures to be implemented to further strengthen our IT environment as the Company grows and evolves. We have a response plan governing our assessment, response and notifications internally and externally upon the occurrence of a cybersecurity incident that is led by our CIO, in coordination with other senior leaders. Depending on the nature and severity of an incident, our CIO and CEO may escalate notification of the incident to the Audit Committee and to the Board. The Board’s Audit Committee oversees our global cybersecurity risk environment, strategy, and priorities. Our CIO, together with other senior leaders, regularly reviews the Company’s global information technology (IT) system with the Committee, including reports on risks from cybersecurity threats and the Company’s processes to monitor the prevention, detection, mitigation and remediation of cybersecurity incidents. In 2024, this review included the CIO’s assessment of our IT and cybersecurity capabilities and continuous improvement plan. Our CIO’s report to the Audit Committee is provided annually or, if the circumstances warrant, more frequently. In addition, the Board receives periodic reports from the Audit Committee and our CIO relating to risks from cybersecurity threats. Each employee is responsible for taking proper security precautions when using the Company’s network and IT systems. ChampionX provides IT and cybersecurity training to employees at least once a year, regularly distributes cybersecurity tips, and conducts regular education campaigns to heighten employee awareness of phishing and other cybersecurity threats.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our CIO and other senior leaders regularly review the results of the assessments, tabletop exercise, cybersecurity roadmap progress, and monthly operational metrics to stay informed about risks from cybersecurity threats and monitor the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	The CIO has served in various roles in information technology and information security for over 25 years, including serving as vice president of global infrastructure and operations, infrastructure security, access management, cloud security, disaster recovery and change management, and vice president of enterprise business applications, architecture and operations. The CIO holds a master’s degree in technology policy management and a doctorate in information technology management, in addition to serving on multiple advisory boards within academia and industry. The other senior leaders who collaborate with the CIO on reviews of the Company’s IT system and cybersecurity risk environment include a senior director of global IT cybersecurity and a senior director of global infrastructure, each of whom have over 20 years of experience managing risks in various roles, including risks arising from cybersecurity threats.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our CIO and other senior leaders regularly review the results of the assessments, tabletop exercise, cybersecurity roadmap progress, and monthly operational metrics to stay informed about risks from cybersecurity threats and monitor the prevention, detection, mitigation and remediation of cybersecurity incidents. They report this information to the Audit Committee and ERM Committee as appropriate, together with measures to be implemented to further strengthen our IT environment as the Company grows and evolves. We have a response plan governing our assessment, response and notifications internally and externally upon the occurrence of a cybersecurity incident that is led by our CIO, in coordination with other senior leaders. Depending on the nature and severity of an incident, our CIO and CEO may escalate notification of the incident to the Audit Committee and to the Board. The Board’s Audit Committee oversees our global cybersecurity risk environment, strategy, and priorities. Our CIO, together with other senior leaders, regularly reviews the Company’s global information technology (IT) system with the Committee, including reports on risks from cybersecurity threats and the Company’s processes to monitor the prevention, detection, mitigation and remediation of cybersecurity incidents. In 2024, this review included the CIO’s assessment of our IT and cybersecurity capabilities and continuous improvement plan. Our CIO’s report to the Audit Committee is provided annually or, if the circumstances warrant, more frequently. In addition, the Board receives periodic reports from the Audit Committee and our CIO relating to risks from cybersecurity threats. Each employee is responsible for taking proper security precautions when using the Company’s network and IT systems. ChampionX provides IT and cybersecurity training to employees at least once a year, regularly distributes cybersecurity tips, and conducts regular education campaigns to heighten employee awareness of phishing and other cybersecurity threats.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany accounts and transactions have been eliminated.
Use of estimates	Use of estimates— The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Such estimates include, but are not limited to, net realizable value of inventories; allowance for doubtful accounts; pension and post-retirement plans; future cash flows associated with impairment testing of goodwill; indefinite-lived intangible assets and other long-lived assets; estimates related to income taxes; and estimates related to contingencies.
Cash and cash equivalents	Cash and cash equivalents— Cash equivalents are highly liquid, short-term investments with original maturities of three months or less from their date of purchase.
Receivables, net	Receivables, net—
Inventories, net	Inventories, net—
Property, plant and equipment, net	Property, plant and equipment, net— Property, plant and equipment is recorded at cost, or fair value for those assets acquired in a business combination. Depreciation is applied on the straight-line basis over the estimated useful lives of our assets as follows: buildings and improvements 5 to 40 years; machinery and equipment 1 to 20 years; and software 3 to 7 years. Expenditures for maintenance and repairs are expensed as incurred. Gains and losses are realized upon the sale or disposition of assets and are recorded in other expense (income), net on our consolidated statements of income. Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate the carrying value of the long-lived asset may not be recoverable. The carrying value of a long-lived asset is not recoverable to the extent it exceeds the sum of undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that an impairment loss has occurred, the impairment loss is measured as the amount by which the carrying value of the long-lived asset exceeds its fair value.
Goodwill and intangible assets, net	Goodwill and intangible assets, net— We review goodwill for impairment annually or more frequently if events or changes in circumstances indicate that the carrying amount of such goodwill allocated to reporting units may exceed their fair value. We initially assess goodwill for impairment based on qualitative factors to determine whether it is necessary to perform a goodwill impairment test. When performing the quantitative assessment, we estimate fair value of our reporting units using an income approach. Our income-based valuation method determines the present value of estimated future cash flows to estimate the fair value of a reporting unit, which requires the use of significant unobservable inputs, and represents a Level 3 fair value measurement. Significant assumptions used in estimating our reporting unit fair values include discount rate, revenue growth rates, future operating margins, future capital expenditures, changes in working capital requirements and terminal growth rates. If the carrying amount exceeds the fair value, an impairment charge will be recognized in an amount equal to the excess; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Our finite-lived acquired intangible assets are amortized on a straight-line basis over their estimated useful lives, which generally range from 3 to 15 years. Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of the intangible asset may not be recoverable. The carrying amount of an intangible asset is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that an impairment loss has occurred, the loss is measured as the amount by which the carrying amount of the intangible asset exceeds its fair value. We have two intangible assets with an indefinite life which are tested annually for impairment.
Revenue Recognition	Revenue Recognition— Revenue is recognized upon the transfer of control of the related goods and services to the customer. The majority of our revenue is generated through the manufacture and sale of a broad range of specialized products and components, with revenue recognized upon transfer of control, which typically occurs as title and risk of loss transfers. We account for shipping and handling activities performed after control of a good has been transferred to the customer as a contract fulfillment cost rather than a separate performance obligation. Revenue arrangements with customers may require delivery, installation, testing, or other acceptance provisions to be satisfied before revenue is recognized. Service revenue is recognized as the services are performed. Estimates are used to determine the amount of variable consideration in contracts, as well as the determination of the standalone selling price among separate performance obligations. No material variable consideration has been identified within our contracts.
Lessor accounting	Lessor accounting —Our lease arrangements generally allow customers to rent equipment on a daily basis with no stated end date. Customers may return the equipment at any point subsequent to the lease commencement date without penalty. We account for these arrangements as a daily renewal option beginning on the lease commencement date, with the lease term determined as the period in which it is reasonably certain the option will be exercised. Based on our assessment of the lease classification criteria, our lease arrangements have been classified as operating leases. Our lease arrangements generally include lease and non-lease components for which revenue is recognized based on each component’s standalone selling price. Lease revenue is recognized on a straight-line basis over the term of the lease and is included in lease and other revenue in the consolidated statements of income. Non-lease components related to our lease arrangements, such as installation, monitoring and field service support, are recognized in accordance with our revenue recognition accounting policy. Assets in our lease program are reported in property, plant, and equipment, net on our consolidated balance sheets and are depreciated over their estimated useful lives. Certain contracts allow for leased equipment damaged in operation to be charged to the customer. Charges for damaged leased equipment is recorded as product revenue and the remaining net book value of the leased asset is expensed as costs of goods and services in the consolidated statements of income.
Lessee accounting	Lessee accounting
Stock-based compensation	Stock-based compensation— The cost of stock-based awards is measured at the grant date and is based on the fair value of the award. The value of the portion of the award that is expected to ultimately vest is recognized as expense on a straight-line basis, generally over the explicit service period and is included in selling, general and administrative expense in our consolidated statements of income. Forfeitures are accounted for as they occur, but are not material to the financial statements. Expense for awards granted to retirement-eligible employees is recorded over the period from the date of grant through the date the employee first becomes eligible to retire and is no longer required to provide service.
Research and development costs	Research and development costs—
Income Taxes	Income Taxes— The Global Intangible Low-Taxed Income (“GILTI”) provisions of the Tax Reform Act require us to include in our U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. We have elected to account for GILTI tax in the period in which it is incurred.
Earnings per share (“EPS”)	Earnings per share (“EPS”)— Basic EPS is computed using the weighted-average number of common shares outstanding during the year. We use the treasury stock method to compute diluted EPS which gives effect to the potential dilution of earnings that could have occurred if additional shares were issued for awards granted under our incentive compensation and stock plan. The treasury stock method assumes proceeds that would be obtained upon exercise of awards granted under our incentive compensation and stock plan are used to purchase outstanding common stock at the average market price during the period.
Investments in Affiliated Companies	Investments in Affiliated Companies—
Fair value measurements	Fair value measurements— We record our financial assets and financial liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date (an exit price). In the absence of active markets for the identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy: • Level 1 — Unadjusted quoted prices in active markets for identical assets and liabilities. • Level 2 — Observable inputs other than quoted prices included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. • Level 3 — Unobservable inputs reflecting management’s own assumptions about the assumptions market participants would use in pricing the asset or liability.
Derivative financial instruments	Derivative financial instruments—
Foreign currency	Foreign currency—
New Accounting Standards Issued and Adopted	New Accounting Standards Issued In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2024-03, “Disaggregation of Income Statement Expenses (DISE)” which requires a public business entity to disclose the nature of certain expenses within the footnotes of the financial statements, including purchases of inventory, employee compensation, depreciation, intangible asset amortization and the total amount of selling expenses. The guidance is effective for annual periods beginning after December 15, 2026, with early adoption permitted. In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2023-09, “Improvements to Income Tax Disclosure” which requires a public business entity to disclose disaggregated information about a reporting entity’s effective tax rate reconciliation, using both percentages and reporting currency amounts for specific standardized categories. Separate disclosures will be required for any reconciling items that are equal to or greater than a specified quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. Accounting Standards Adopted In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures” which requires a public business entity to disclose its significant segment expense categories and amounts for each reportable segment. A significant segment expense is an expense that is significant to the segment, regularly provided to or easily computes from information regularly provided to the Chief operating decision maker (CODM), and included in the reported measure of segment profit or loss. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 3—Segment Information for significant expense categories and amounts for each reportable segment.

BASIS OF PRESENTATION AND SUM_3

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Inventory	Inventories, net consisted of the following: December 31, (in thousands) 2024 2023 Raw materials $ 131,605 $ 137,402 Work in progress 24,431 16,915 Finished goods 420,282 445,437 576,318 599,754 Inventory reserve (27,997) (29,081) LIFO adjustments (1) (51,490) (49,124) Inventories, net $ 496,831 $ 521,549 _______________________ (1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Revenue and Operating Profit	Segment revenue and segment operating profit Year Ended December 31, 2024 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue 2,288,886 1,042,369 211,828 94,296 3,637,379 (3,396) 3,633,983 Cost of goods and services 1,548,993 701,924 124,349 69,921 2,445,187 94 2,445,281 Selling, general and administrative expense 373,191 218,290 38,859 12,227 642,567 78,065 720,632 Other segment items 2,655 (1,685) (29,849) 70 (28,809) (1,864) (30,673) Segment operating profit 364,047 123,840 78,469 12,078 578,434 (79,691) 498,743 Interest expense, net — — — — — 55,868 55,868 Income before income taxes 364,047 123,840 78,469 12,078 578,434 (135,559) 442,875 Year Ended December 31, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue 2,404,377 1,003,146 215,721 96,154 3,719,398 38,887 3,758,285 Cost of goods and services 1,683,121 692,994 129,104 71,979 2,577,198 41,448 2,618,646 Selling, general and administrative expense 345,000 193,349 41,102 13,484 592,935 40,097 633,032 Other segment items 26,040 (1,606) 34 150 24,618 3,603 28,221 Segment operating profit 350,216 118,409 45,481 10,541 524,647 (46,261) 478,386 Interest expense, net — — — — — 54,562 54,562 Income before income taxes 350,216 118,409 45,481 10,541 524,647 (100,823) 423,824 Year Ended December 31, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total Reportable Segments Corporate and other (1) Total Segment revenue $ 2,347,526 $ 954,646 $ 229,479 $ 145,197 $ 3,676,848 $ 129,100 $ 3,805,948 Cost of goods and services 1,786,227 671,485 135,546 177,643 2,770,901 136,383 2,907,284 Selling, general and administrative expense 302,577 191,817 39,438 17,628 551,460 40,822 592,282 Other segment items 18,786 2,211 (17) 40,138 61,118 3,254 64,372 Segment operating profit 239,936 89,133 54,512 (90,212) 293,369 (51,359) 242,010 Interest expense, net — — — — — 45,204 45,204 Income before income taxes $ 239,936 $ 89,133 $ 54,512 $ (90,212) $ 293,369 $ (96,563) $ 196,806 ____________________ (1) Corporate and other includes costs not directly attributable or allocated to our reportable segments such as overhead and other costs pertaining to corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from June 3, 2020, the date of the Ecolab Merger in which we acquired the Chemical Technologies business, through June 30, 2023. Beginning, July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.
Schedule of Property, Plant and Equipment, Net by Geographical Area	Geographic information December 31, (in thousands) 2024 2023 Property, plant, and equipment, net: United States $ 522,850 $ 522,640 Singapore 72,085 80,526 Canada 64,649 69,974 Other Countries 95,838 100,412 Total property, plant, and equipment, net $ 755,422 $ 773,552
Schedule of Other Segment Information	Other business segment information Segment Assets (in thousands) 2024 2023 2022 Chemical Technologies (1) $ 535,033 $ 647,389 $ 718,882 Production & Automation Technologies 375,492 358,372 371,087 Drilling Technologies 49,998 48,700 52,552 Total segment assets (2) 960,523 1,054,461 1,142,521 Other current assets 603,374 370,956 $ 356,060 Noncurrent assets 1,906,355 1,816,285 1,888,902 Total assets $ 3,470,252 $ 3,241,702 $ 3,387,483 _______________________ (1) Our Chemical Technologies business has an integrated supply chain function that serves the Production Chemical Technologies and Reservoir Chemical Technologies reportable segments. As such, segment assets by each reportable segment has not been provided and is not available, since the Company does not produce or utilize such information. (2) The significant asset categories that is regularly provided to the chief operating decision maker (“CODM”) includes total accounts receivable and inventory. The amounts align with segment level information provided in the CODM package. Capital Expenditures (in thousands) 2024 2023 2022 Chemical Technologies (1) $ 58,805 $ 49,485 $ 41,782 Production & Automation Technologies 76,424 86,029 56,363 Drilling Technologies 5,198 4,700 3,732 Corporate and other 883 2,110 931 Total $ 141,310 $ 142,324 $ 102,808 _______________________ (1) Our Chemical Technologies business has an integrated supply chain function that serves the Production Chemical Technologies and Reservoir Chemical Technologies reportable segments. As such, capital expenditure information by each reportable segment has not been provided and is not available, since the Company does not produce or utilize such information. Depreciation & Amortization (in thousands) 2024 2023 2022 Production Chemical Technologies $ 106,394 $ 105,058 $ 91,875 Production & Automation Technologies 125,884 109,017 103,592 Drilling Technologies 5,465 6,192 6,639 Reservoir Chemical Technologies 6,196 6,471 14,662 Corporate and other 1,886 9,198 25,112 Total $ 245,825 $ 235,936 $ 241,880

ACQUISITIONS, DIVESTITURES AN_2

ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK (Tables)	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Fair Value of Assets Acquired	The following table provides the initial allocation of the purchase price as of the acquisition date. (in thousands) Cash and cash equivalents $ 4,262 Receivables 14,466 Inventories 15,168 Prepaid expenses and other current assets 484 Property, plant, and equipment 1,335 Identifiable intangible assets 53,000 Operating leases right-of-use asset 1,162 Other noncurrent assets 192 Total identifiable assets acquired 90,069 Accounts payable 6,342 Accrued compensation and employee benefits 3,261 Accrued expenses and other current liabilities 4,296 Deferred income taxes 13,849 Operating lease liabilities 1,267 Total liabilities assumed 29,015 Net identifiable assets acquired 61,054 Goodwill 45,005 Total net assets acquired $ 106,059

REVENUE (Tables)

REVENUE (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Revenue disaggregated by geography was as follows: Year Ended December 31, 2024 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 1,024,847 $ 781,260 $ 166,843 $ 50,050 $ — $ 2,023,000 Latin America 307,590 31,792 221 13,141 — 352,744 Middle East & Africa 353,240 78,471 7,565 22,768 (3,396) 458,648 Canada 315,696 68,020 17,815 2,174 — 403,705 Europe 199,727 18,612 15,264 4,370 — 237,973 Asia-Pacific 66,805 10,759 4,120 1,756 — 83,440 Australia 20,981 53,455 — 37 — 74,473 Other — — — — — — Total revenue $ 2,288,886 $ 1,042,369 $ 211,828 $ 94,296 $ (3,396) $ 3,633,983 Year Ended December 31, 2023 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 983,542 $ 763,103 $ 163,776 $ 49,171 $ 20,659 $ 1,980,251 Latin America 522,372 22,727 — 13,182 1,720 560,001 Middle East & Africa 325,142 65,396 10,471 26,553 (1,170) 426,392 Canada 296,001 73,806 14,326 1,423 18 385,574 Europe 196,533 17,641 23,401 2,803 5,121 245,499 Asia-Pacific 48,718 13,556 3,745 2,444 12,539 81,002 Australia 22,739 46,917 — 15 — 69,671 Other 9,330 — 2 563 — 9,895 Total revenue $ 2,404,377 $ 1,003,146 $ 215,721 $ 96,154 $ 38,887 $ 3,758,285 Year Ended December 31, 2022 (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Corporate and other (1) Total United States $ 851,057 $ 738,178 $ 180,912 $ 88,108 $ 76,461 $ 1,934,716 Latin America 594,737 21,756 7 13,887 3,100 633,487 Middle East & Africa 307,154 66,918 6,628 26,876 2,314 409,890 Canada 296,623 73,561 14,529 1,933 116 386,762 Europe 194,034 13,655 20,911 3,439 13,936 245,975 Asia-Pacific 35,536 6,170 6,434 3,115 33,173 84,428 Australia 21,866 34,318 33 299 — 56,516 Other 46,519 90 25 7,540 — 54,174 Total revenue $ 2,347,526 $ 954,646 $ 229,479 $ 145,197 $ 129,100 $ 3,805,948 _______________________ (1) The sales related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from the date of the Ecolab Merger through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.
Schedule of Contract Balances	The beginning and ending contract asset and contract liability balances from contracts with customers were as follows: December 31, (in thousands) 2024 2023 Contract assets $ — $ — Contract liabilities 16,517 27,406

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment, net consisted of the following: December 31, (in thousands) 2024 2023 Land and land improvements $ 120,305 $ 126,151 Buildings and improvements 286,593 311,436 Software 66,540 60,945 Machinery, equipment and other 1,131,449 1,056,387 1,604,887 1,554,919 Accumulated depreciation (849,465) (781,367) Property, plant and equipment, net $ 755,422 $ 773,552 (in thousands) Useful life December 31, 2024 Cable equipment 18 months $ 67,945 Downhole equipment 18 months 68,164 Surface equipment 5 years 122,792 Other lease equipment 3 - 5 years 18,459 277,360 Accumulated depreciation (163,531) Leased assets, net $ 113,829

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill, including changes therein, by reportable segment is below: (in thousands) Production Chemical Technologies Production & Automation Technologies Drilling Technologies Reservoir Chemical Technologies Total December 31, 2022 $ 367,084 $ 211,268 $ 101,136 $ — $ 679,488 Foreign currency translation (10,526) 102 — — (10,424) December 31, 2023 356,558 211,370 101,136 — 669,064 Acquisition (1) — 60,754 — — 60,754 Foreign currency translation (8,998) (1,876) — — (10,874) December 31, 2024 $ 347,560 $ 270,248 $ 101,136 $ — $ 718,944 _______________________ (1)
Schedule of Finite-Lived Intangible Assets	The components of our definite- and indefinite-lived intangible assets were as follows: December 31, 2024 December 31, 2023 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships (1) $ 324,893 $ 177,831 $ 147,062 $ 583,326 $ 438,181 $ 145,145 Unpatented technologies (1) 173,333 96,984 76,349 142,760 75,224 67,536 Trademarks (1) 31,575 12,335 19,240 59,862 39,564 20,298 Patents (1) 35,722 30,323 5,399 36,438 30,664 5,774 Other 6,980 1,216 5,764 — — — 572,503 318,689 253,814 822,386 583,633 238,753 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 577,303 $ 318,689 $ 258,614 $ 827,186 $ 583,633 $ 243,553 _______________________ (1) See Note 4—Acquisitions, Divestitures and Sale-Leaseback for additional information related to the acquisitions completed during the first and third quarters of 2024. We recorded definite-lived intangible assets of $10.4 million for the acquisition of Artificial Lift Performance and $53.0 million for RMSpumptools.
Schedule of Indefinite-Lived Intangible Assets	The components of our definite- and indefinite-lived intangible assets were as follows: December 31, 2024 December 31, 2023 (in thousands) Gross Accumulated Net Gross Accumulated Net Definite-lived Customer relationships (1) $ 324,893 $ 177,831 $ 147,062 $ 583,326 $ 438,181 $ 145,145 Unpatented technologies (1) 173,333 96,984 76,349 142,760 75,224 67,536 Trademarks (1) 31,575 12,335 19,240 59,862 39,564 20,298 Patents (1) 35,722 30,323 5,399 36,438 30,664 5,774 Other 6,980 1,216 5,764 — — — 572,503 318,689 253,814 822,386 583,633 238,753 Indefinite-lived Trademarks 3,600 — 3,600 3,600 — 3,600 In-process research and development 1,200 — 1,200 1,200 — 1,200 4,800 — 4,800 4,800 — 4,800 Total $ 577,303 $ 318,689 $ 258,614 $ 827,186 $ 583,633 $ 243,553 _______________________ (1) See Note 4—Acquisitions, Divestitures and Sale-Leaseback for additional information related to the acquisitions completed during the first and third quarters of 2024. We recorded definite-lived intangible assets of $10.4 million for the acquisition of Artificial Lift Performance and $53.0 million for RMSpumptools.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Estimated future amortization expense related to intangible assets held as of December 31, 2024, is as follows: (in thousands) Estimated Amortization 2025 $ 46,946 2026 46,588 2027 35,480 2028 25,813 2029 22,312

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term debt	Long-term debt consisted of the following: December 31, (in thousands) 2024 2023 2022 Revolving Credit Facility $ — $ — 2022 Term Loan Facility 612,559 618,762 Total 612,559 618,762 Net unamortized discounts and issuance costs (14,903) (18,276) Total long-term debt 597,656 600,486 Current portion of long-term debt (1) (6,203) (6,203) Long-term debt, less current portion $ 591,453 $ 594,283 _______________________ (1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of December 31, 2024.
Schedule of Contractual Obligation, Maturity Schedule	As of December 31, 2024, aggregate contractual future principal payments on long-term debt are as follows: (in thousands) Principal Payments ( 1) 2025 $ 6,203 2026 6,203 2027 6,203 2028 6,203 2029 587,747 Total $ 612,559 _______________________ (1) Principal payments included relate to our 2022 Term Loan Facility. See Note 10—Leases for future payments related to finance lease obligations.

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Leases, Balance Sheet Information	Leases are presented in our consolidated balance sheet as follows: December 31, (in thousands) Balance Sheet Classification 2024 2023 Right-of Use Assets: Finance leases Property, plant, and equipment, net $ 54,025 $ 41,554 Operating leases Operating lease right-of-use assets 100,427 69,561 Total lease right-of-use assets 154,452 111,115 Lease Liabilities: Finance leases - current Accrued expenses and other current liabilities $ 14,688 $ 11,723 Finance leases Other long-term liabilities 41,586 31,202 Operating leases - current Current portion of operating lease liabilities 16,794 23,292 Operating leases Operating lease liabilities 81,340 41,975 Total lease liabilities $ 154,408 $ 108,192
Schedule of Lease Costs and Other Information	Components of total lease cost were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost: Amortization of right-of-use assets $ 14,946 $ 11,114 Interest on lease liabilities 3,792 2,480 Operating lease cost 32,809 35,163 Short-term and variable lease cost 13,582 18,845 Sublease income (300) — Total lease cost $ 64,829 $ 67,602 December 31, 2024 2023 Weighted-average remaining lease term (years): Operating lease 12.5 7.1 Finance lease 4.2 4.1 Weighted-average discount rate: Operating lease 7.8 % 6.4 % Finance lease 7.7 % 7.3 % Supplemental cash flow information related to our lease liabilities is as follows: Statement of Cash Flows Classification December 31, (in thousands) 2024 2023 Cash paid for amounts included in measurement of lease liabilities: Operating leases (1) Operating $ 32,155 $ 35,297 Finance leases - interest Operating $ 3,792 $ 2,480 Finance leases - principal Financing $ 13,838 $ 9,982 Supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets: Operating leases Non-cash $ 52,265 $ 4,197 Finance leases Non-cash $ 23,034 $ 31,113 _______________________ (1) Cash required by operating leases is reported net of operating lease expense in the operating section of our consolidated statements of cash flows in accrued expenses and other liabilities.
Schedule of Future Minimum Operating Lease Payments	Future minimum payments, as determined in accordance with ASC 842, on our operating and finance leases as of December 31, 2024 are as follows: (in thousands) Operating Finance 2025 $ 23,476 $ 18,099 2026 17,453 15,367 2027 13,625 14,086 2028 9,842 10,324 2029 8,240 4,729 Thereafter 87,179 2,856 Total future minimum lease payments 159,815 65,461 Interest included within lease payments (61,681) (9,187) Total lease liabilities $ 98,134 $ 56,274
Schedule of Future Minimum Financing Lease Payments	Future minimum payments, as determined in accordance with ASC 842, on our operating and finance leases as of December 31, 2024 are as follows: (in thousands) Operating Finance 2025 $ 23,476 $ 18,099 2026 17,453 15,367 2027 13,625 14,086 2028 9,842 10,324 2029 8,240 4,729 Thereafter 87,179 2,856 Total future minimum lease payments 159,815 65,461 Interest included within lease payments (61,681) (9,187) Total lease liabilities $ 98,134 $ 56,274
Schedule of Leased Assets	Property, plant and equipment, net consisted of the following: December 31, (in thousands) 2024 2023 Land and land improvements $ 120,305 $ 126,151 Buildings and improvements 286,593 311,436 Software 66,540 60,945 Machinery, equipment and other 1,131,449 1,056,387 1,604,887 1,554,919 Accumulated depreciation (849,465) (781,367) Property, plant and equipment, net $ 755,422 $ 773,552 (in thousands) Useful life December 31, 2024 Cable equipment 18 months $ 67,945 Downhole equipment 18 months 68,164 Surface equipment 5 years 122,792 Other lease equipment 3 - 5 years 18,459 277,360 Accumulated depreciation (163,531) Leased assets, net $ 113,829

RESTRUCTURING (Tables)

RESTRUCTURING (Tables)	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Other Related Charges	The following table presents the restructuring and other related charges by segment as classified in our consolidated statements of income. Years Ended December 31, (in thousands) 2024 2023 2022 Segment restructuring charges: Production Chemical Technologies $ 6,023 $ 4,662 $ 13,899 Production & Automation Technologies 5,073 770 1,111 Drilling Technologies 234 — — Reservoir Chemical Technologies — 856 47,692 Corporate and other — 6 5,400 Total $ 11,330 $ 6,294 $ 68,102 Statements of Income classification: Cost of goods and services $ 4,998 $ 2,571 $ 47,216 Selling, general and administrative expense 6,332 3,723 20,886 Total $ 11,330 $ 6,294 $ 68,102 The following table details our restructuring accrual activities during the year ended December 31, 2024: (in thousands) Restructuring Accrual Balance December 31, 2023 $ 13,974 Restructuring charges 11,330 Write-offs (3,805) Payments (9,027) December 31, 2024 $ 12,472

EQUITY AND CASH INCENTIVE PRO_2

EQUITY AND CASH INCENTIVE PROGRAMS (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense relating to all stock-based incentive plans was as follows: Years Ended December 31, 2024 2023 2022 Stock-based compensation expense $ 25,770 $ 23,749 $ 20,089 Tax benefit (5,788) (5,310) (4,492) Stock-based compensation expense, net of tax $ 19,982 $ 18,439 $ 15,597
Schedule of Activity Related to SARs Outstanding	A summary of activity relating to SARs outstanding for the year ended December 31, 2024, is as follows: SARs Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2024 235,125 $ 31.89 Forfeited / expired (19,422) 35.53 Exercised (10,834) 33.22 Outstanding at December 31, 2024 204,869 $ 31.47 1.6 $ 117 Exercisable at December 31, 2024 204,869 $ 31.47 1.6 $ 117
Schedule of Other Information Related to the Exercise of SARs	Other information regarding the exercise of SARs is presented below: (in thousands) 2024 2023 2022 SARs: Fair value of SARs that became exercisable $ — $ — $ — Aggregate intrinsic value of SARs exercised 37 169 634
Schedule of Performance Shares	A summary of activity for performance share awards under the 2018 Plan for the year ended December 31, 2024, is as follows: Shares Weighted-Average Unvested at January 1, 2024 901,661 $ 26.04 Granted 271,190 32.65 Forfeited (4,310) 28.54 Vested (511,602) 21.99 Performance adjustment (1) 150,319 21.97 Unvested at December 31, 2024 807,258 $ 29.60 ______________________ (1) Represents the additional shares that were issued to participants upon vesting of the awards due to the performance factor being exceeded for the three-year performance period.
Schedule of Restricted Stock Unit Activity	A summary of activity for restricted stock, restricted stock units, directors’ shares and deferred stock units for the year ended December 31, 2024, is as follows: Shares (1) Weighted-Average Unvested at January 1, 2024 1,537,044 $ 24.37 Granted 644,320 30.14 Forfeited (111,281) 26.99 Vested (644,034) 22.78 Unvested at December 31, 2024 1,426,049 $ 27.44 _______________________ (1) Shares unvested on the dates indicated includes deferred stock units recorded for non-employee directors who elected to defer receipt of directors’ shares awarded to a later date; shares granted includes directors’ shares and deferred stock units awarded in the year; and shares vested includes directors’ shares awarded in the year and deferred stock units recorded in previous years that were issued in accordance with a non-employee director’s deferral election.
Schedule of Non-Qualified Stock Options	A summary of activity for non-qualified stock options for the year ended December 31, 2024 is as follows: Non-Qualified Stock Options Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2024 2,728,376 $ 6.41 Granted — — Forfeited / expired — — Exercised (378,195) 6.00 Outstanding at December 31, 2024 2,350,181 $ 6.47 2.4 $ 48,373 Exercisable at December 31, 2024 2,350,181 $ 6.47 2.4 $ 48,373

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings (Loss) Per Share, Basic and Diluted	A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows: Years Ended December 31, (in thousands, except per share data) 2024 2023 2022 Net income attributable to ChampionX $ 320,266 $ 314,238 $ 154,969 Weighted-average number of shares outstanding 190,578 196,083 201,740 Dilutive effect of stock-based compensation 3,065 3,823 5,519 Total shares and dilutive securities 193,643 199,906 207,259 Basic earnings per share attributable to ChampionX $ 1.68 $ 1.60 $ 0.77 Diluted earnings per share attributable to ChampionX $ 1.65 $ 1.57 $ 0.75

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured on Recurring Basis	The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows: Carrying Amount Measurement Level December 31, (in thousands) 2024 2023 Assets Foreign currency forward contracts Level 2 $ 10,078 $ 6,231 Interest rate swaps Level 2 4,199 5,599 Total $ 14,277 $ 11,830 Liabilities Foreign currency forward contracts Level 2 $ 13,430 $ 5,354 Interest rate swaps Level 2 13 — Total $ 13,443 $ 5,354
Schedule of Fair Value of Long-Term Debt	The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were: December 31, 2024 December 31, 2023 (in thousands) Carrying Amount Fair Value Carrying Amount Fair Value 2022 Revolving Credit Facility $ — $ — $ — $ — 2022 Term Loan Facility $ 612,559 $ 613,324 $ 618,762 $ 623,402

DERIVATIVES AND HEDGING TRANS_2

DERIVATIVES AND HEDGING TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Values of Outstanding Derivatives	The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the consolidated balance sheet. Derivative Assets Derivative Liabilities December 31, December 31, (in thousands) 2024 2023 2024 2023 Prepaid expenses and other current assets $ 12,455 $ 11,004 $ — $ — Other non-current assets 1,822 826 — — Accrued expenses and other current liabilities — — 13,443 5,354 Other long-term liabilities — — — — $ 14,277 $ 11,830 $ 13,443 $ 5,354 The following table summarizes the notional values of the Company’s outstanding derivatives: December 31, (in thousands) 2024 2023 Notional value of foreign currency forward contracts and interest rate swaps $ 941,784 $ 892,711
Schedule of Loss on Derivative Instruments	The loss (gain) on all derivative instruments recognized is summarized below: Years Ended December 31, (in thousands) 2024 2023 2022 Loss (gain) reclassified from AOCI to income on cash flow hedges: Cost of goods and services $ (1,023) $ (2,571) $ (1,665) Interest expense (6,399) (5,034) 549 Loss on derivatives not designated as hedging instruments: Foreign currency transaction losses, net 5,058 1,195 7,147 Total loss (gain) on derivative instruments $ (2,364) $ (6,410) $ 6,031

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Domestic And Foreign Components Of Income (Loss) Before Income Taxes	Domestic and foreign components of income before income taxes were as follows: Years Ended December 31, (in thousands) 2024 2023 2022 Domestic $ 243,620 $ 304,725 $ 58,141 Foreign 199,255 119,099 138,665 Income before income taxes $ 442,875 $ 423,824 $ 196,806
Schedule of Provision For (Benefit From) Income Tax	The provision for (benefit from) income taxes consisted of: Years Ended December 31, (in thousands) 2024 2023 2022 Current: U.S. federal $ 76,037 $ 74,022 $ 49,997 State and local 8,534 9,234 11,147 Foreign 54,048 44,121 24,381 Total current 138,619 127,377 85,525 Deferred: U.S. federal (22,880) (17,219) (35,207) State and local (1,020) (3,198) (4,900) Foreign 1,027 (1,855) (5,175) Total deferred (22,873) (22,272) (45,282) Provision for income taxes $ 115,746 $ 105,105 $ 40,243
Schedule of Effective Income Tax Rate Reconciliation	The effective income tax rate was different from the statutory U.S. federal income tax rate due to the following: Years Ended December 31, 2024 2023 2022 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Net difference resulting from: State and local taxes, net of federal income tax benefit 0.9 1.1 0.6 Foreign withholding tax 4.2 4.0 5.7 Foreign derived intangible income (1.0) (1.9) (1.0) Foreign operations tax effect (1.4) 2.1 2.8 Research and experimentation tax credits (1.3) (1.3) (1.5) Foreign tax credit (1.2) (3.9) (4.5) Nondeductible expenses — 0.2 0.5 Branch income 1.5 1.2 3.5 Tax return to accrual adjustments (0.3) (1.6) (2.1) State deferred taxes 0.2 (0.2) (1.0) Goodwill impairment — — 1.8 Foreign inclusions (including global intangible low-taxed income) 0.5 4.3 3.5 Change in valuation allowance 2.8 0.8 (7.3) Stock compensation (1.9) (2.1) (3.6) Nondeductible officer compensation 0.9 0.7 0.8 Other 1.2 0.4 1.2 Effective income tax rate 26.1 % 24.8 % 20.4 %
Schedule of Significant Components Of Deferred Tax Assets And Liabilities	Significant components of deferred tax assets and liabilities were as follows: December 31, (in thousands) 2024 2023 Deferred tax assets attributable to: Accrued compensation $ 13,654 $ 10,558 Accrued expenses 9,118 6,565 Inventories 3,146 4,674 Net operating loss and other carryforwards 37,928 31,355 Accounts receivable 13,646 13,401 Lease liability 14,404 7,198 Research and Development 41,202 31,324 Other assets 7,167 1,258 Deferred tax assets 140,265 106,333 Valuation allowance (45,992) (33,031) Deferred tax assets, net of valuation allowance $ 94,273 $ 73,302 Deferred tax liabilities attributable to: Inventories $ (1,142) $ (3,462) Intangible assets, including goodwill (51,318) (38,651) Property, plant and equipment (56,072) (65,559) Foreign withholding taxes (19,650) (15,934) Lease asset (15,308) (7,012) Investment in subsidiary (2,724) (1,950) Long-term liabilities (2,653) (3,128) Deferred tax liabilities (148,867) (135,696) Net deferred tax liabilities $ (54,594) $ (62,394) Classified as follows in the consolidated balance sheets: Other non-current assets 7,779 9,103 Deferred income taxes (62,373) (71,497) Net deferred tax liabilities $ (54,594) $ (62,394)

SUPPLY CHAIN FINANCE (Tables)

SUPPLY CHAIN FINANCE (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Supply Chain Finance Payables	(in thousands) Supply Chain Finance Payables Outstanding December 31, 2023 $ 30,783 Purchases 186,479 Payments (186,390) Other, including foreign currency translation (288) December 31, 2024 $ 30,584

CASH FLOW INFORMATION (Tables)

CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash and Non-cash Supplemental Information	Cash payments for income taxes and cash payments for interest incurred related to our debt are as follows: Years Ended December 31, (in thousands) 2024 2023 2022 Cash information: Cash paid for income taxes $ 78,163 $ 116,677 $ 127,271 Cash paid for interest $ 52,118 $ 57,267 $ 46,781 Net increase (decrease) in accounts payable for capital expenditures $ (7,795) $ 4,321 $ (6,803)
Schedule of Supplemental Cash Flow Information Related to Leases	Components of total lease cost were as follows: Years Ended December 31, (in thousands) 2024 2023 Finance lease cost: Amortization of right-of-use assets $ 14,946 $ 11,114 Interest on lease liabilities 3,792 2,480 Operating lease cost 32,809 35,163 Short-term and variable lease cost 13,582 18,845 Sublease income (300) — Total lease cost $ 64,829 $ 67,602 December 31, 2024 2023 Weighted-average remaining lease term (years): Operating lease 12.5 7.1 Finance lease 4.2 4.1 Weighted-average discount rate: Operating lease 7.8 % 6.4 % Finance lease 7.7 % 7.3 % Supplemental cash flow information related to our lease liabilities is as follows: Statement of Cash Flows Classification December 31, (in thousands) 2024 2023 Cash paid for amounts included in measurement of lease liabilities: Operating leases (1) Operating $ 32,155 $ 35,297 Finance leases - interest Operating $ 3,792 $ 2,480 Finance leases - principal Financing $ 13,838 $ 9,982 Supplemental non-cash information on lease liabilities arising from obtaining right-of-use assets: Operating leases Non-cash $ 52,265 $ 4,197 Finance leases Non-cash $ 23,034 $ 31,113 _______________________ (1) Cash required by operating leases is reported net of operating lease expense in the operating section of our consolidated statements of cash flows in accrued expenses and other liabilities.

BASIS OF PRESENTATION AND SUM_4

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 131,605	$ 137,402
Work in progress	24,431	16,915
Finished goods	420,282	445,437
Inventory, gross	576,318	599,754
Inventory reserve	(27,997)	(29,081)
LIFO Adjustments	(51,490)	(49,124)
Inventories, net	$ 496,831	$ 521,549

BASIS OF PRESENTATION AND SUM_5

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Apr. 02, 2024 $ / shares shares	Dec. 31, 2024 USD ($) asset $ / shares	Dec. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($)	Apr. 03, 2024 USD ($)
Property, Plant and Equipment [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.01	$ 0.01
Percentage of LIFO inventory		28%	28%
Number of indefinite-lived intangible assets | asset		2
Research and development expense		$ 56,300	$ 53,300	$ 45,100
Accrued foreign withholding taxes on undistributed foreign earnings		$ 19,650	$ 15,934
Minimum | Other
Property, Plant and Equipment [Line Items]
Useful life of acquired intangibles (in years)		3 years
Maximum | Other
Property, Plant and Equipment [Line Items]
Useful life of acquired intangibles (in years)		15 years
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		5 years
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		40 years
Machinery, equipment and other | Minimum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		1 year
Machinery, equipment and other | Maximum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		20 years
Software | Minimum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		3 years
Software | Maximum
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)		7 years
Merger Agreement
Property, Plant and Equipment [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 10,000
Business combination, consideration transferred, equity interests issued and issuable, conversion ratio (in shares) | shares	735,000
Acquisition related costs		$ 37,800
Merger Agreement | Schlumberger Limited
Property, Plant and Equipment [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 10,000
Business combination, possible termination fee					$ 326,600

SEGMENT INFORMATION - Schedule

SEGMENT INFORMATION - Schedule of Segment Revenue and Segment Operating Profit (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Segment revenue	$ 3,633,983	$ 3,758,285	$ 3,805,948
Cost of goods and services	2,445,281	2,618,646	2,907,284
Selling, general and administrative expense	720,632	633,032	592,282
Other segment items	(30,673)	28,221	64,372
Segment operating profit	498,743	478,386	242,010
Interest expense, net	55,868	54,562	45,204
Income before income taxes	442,875	423,824	196,806
Operating Segments
Segment Reporting Information [Line Items]
Segment revenue	3,637,379	3,719,398	3,676,848
Cost of goods and services	2,445,187	2,577,198	2,770,901
Selling, general and administrative expense	642,567	592,935	551,460
Other segment items	(28,809)	24,618	61,118
Segment operating profit	578,434	524,647	293,369
Interest expense, net	0	0	0
Income before income taxes	578,434	524,647	293,369
Operating Segments | Production Chemical Technologies
Segment Reporting Information [Line Items]
Segment revenue	2,288,886	2,404,377	2,347,526
Cost of goods and services	1,548,993	1,683,121	1,786,227
Selling, general and administrative expense	373,191	345,000	302,577
Other segment items	2,655	26,040	18,786
Segment operating profit	364,047	350,216	239,936
Interest expense, net	0	0	0
Income before income taxes	364,047	350,216	239,936
Operating Segments | Production & Automation Technologies
Segment Reporting Information [Line Items]
Segment revenue	1,042,369	1,003,146	954,646
Cost of goods and services	701,924	692,994	671,485
Selling, general and administrative expense	218,290	193,349	191,817
Other segment items	(1,685)	(1,606)	2,211
Segment operating profit	123,840	118,409	89,133
Interest expense, net	0	0	0
Income before income taxes	123,840	118,409	89,133
Operating Segments | Drilling Technologies
Segment Reporting Information [Line Items]
Segment revenue	211,828	215,721	229,479
Cost of goods and services	124,349	129,104	135,546
Selling, general and administrative expense	38,859	41,102	39,438
Other segment items	(29,849)	34	(17)
Segment operating profit	78,469	45,481	54,512
Interest expense, net	0	0	0
Income before income taxes	78,469	45,481	54,512
Operating Segments | Reservoir Chemical Technologies
Segment Reporting Information [Line Items]
Segment revenue	94,296	96,154	145,197
Cost of goods and services	69,921	71,979	177,643
Selling, general and administrative expense	12,227	13,484	17,628
Other segment items	70	150	40,138
Segment operating profit	12,078	10,541	(90,212)
Interest expense, net	0	0	0
Income before income taxes	12,078	10,541	(90,212)
Corporate and other
Segment Reporting Information [Line Items]
Segment revenue	(3,396)	38,887	129,100
Cost of goods and services	94	41,448	136,383
Selling, general and administrative expense	78,065	40,097	40,822
Other segment items	(1,864)	3,603	3,254
Segment operating profit	(79,691)	(46,261)	(51,359)
Interest expense, net	55,868	54,562	45,204
Income before income taxes	$ (135,559)	$ (100,823)	$ (96,563)

SEGMENT INFORMATION - Schedul_2

SEGMENT INFORMATION - Schedule of Geographic Segment Information (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant, and equipment, net	$ 755,422	$ 773,552
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant, and equipment, net	522,850	522,640
Singapore
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant, and equipment, net	72,085	80,526
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant, and equipment, net	64,649	69,974
Other Countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant, and equipment, net	$ 95,838	$ 100,412

SEGMENT INFORMATION - Schedul_3

SEGMENT INFORMATION - Schedule of Other Business Segment Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total segment assets	$ 960,523	$ 1,054,461	$ 1,142,521
Other current assets	603,374	370,956	356,060
Noncurrent assets	1,906,355	1,816,285	1,888,902
Total assets	3,470,252	3,241,702	3,387,483
Capital expenditures	141,310	142,324	102,808
Depreciation and amortization	245,825	235,936	241,880
Operating Segments | Production Chemical Technologies
Segment Reporting Information [Line Items]
Total segment assets	535,033	647,389	718,882
Capital expenditures	58,805	49,485	41,782
Depreciation and amortization	106,394	105,058	91,875
Operating Segments | Production & Automation Technologies
Segment Reporting Information [Line Items]
Total segment assets	375,492	358,372	371,087
Capital expenditures	76,424	86,029	56,363
Depreciation and amortization	125,884	109,017	103,592
Operating Segments | Drilling Technologies
Segment Reporting Information [Line Items]
Total segment assets	49,998	48,700	52,552
Capital expenditures	5,198	4,700	3,732
Depreciation and amortization	5,465	6,192	6,639
Operating Segments | Reservoir Chemical Technologies
Segment Reporting Information [Line Items]
Depreciation and amortization	6,196	6,471	14,662
Corporate and other
Segment Reporting Information [Line Items]
Capital expenditures	883	2,110	931
Depreciation and amortization	$ 1,886	$ 9,198	$ 25,112

ACQUISITIONS, DIVESTITURES AN_3

ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK - Additional Information (Details)					3 Months Ended	12 Months Ended
	Jul. 08, 2024 USD ($)	Mar. 29, 2024 USD ($) property	Feb. 26, 2024 USD ($)	Jan. 05, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($)
Business Acquisition [Line Items]
Goodwill						$ 718,944,000	$ 669,064,000	$ 679,488,000
Asset impairment charges						0	0	39,617,000
Number of buildings in sale-leaseback agreement | property		3
Sale leaseback transaction, net book value		$ 14,100,000
Sale leaseback transaction, gross proceeds		$ 45,500,000
Sale leaseback transaction, lease term		20 years
Proceeds from sale-leaseback transaction		$ 44,300,000				44,292,000	0	0
Sale leaseback transaction, annual base payments		$ 3,300,000
Sale leaseback transaction, extension period		7 years
(Gain) loss on sale-leaseback transaction and disposal group		$ 29,800,000				29,826,000	(12,965,000)	(16,515,000)
Operating lease right-of-use assets		37,700,000				100,427,000	$ 69,561,000
Total lease liabilities		$ 37,700,000				98,134,000
Disposal Group, Not Discontinued Operations | CT Russia Business
Business Acquisition [Line Items]
Asset impairment charges						$ 0		$ 16,500,000
Recoverable value on divestiture									$ 0
Gain (charge) on divestiture					$ 13,000,000
OTS Consulting Services LLP
Business Acquisition [Line Items]
Consideration transferred				$ 8,700,000
Goodwill				$ 6,400,000
Artificial Lift Performance Limited
Business Acquisition [Line Items]
Consideration transferred			$ 13,400,000
Goodwill			9,400,000
Business combination, earn out arrangements, range of outcomes, value, high			$ 3,000,000
Business combination, earn out arrangements, term			2 years
Identifiable intangible assets			$ 10,400,000
Artificial Lift Performance Limited | Payable on First Anniversary of Closing Date
Business Acquisition [Line Items]
Future payments contingent upon performance			1,700,000
Artificial Lift Performance Limited | Holdback Payment and Earn-Out Consideration
Business Acquisition [Line Items]
Future payments contingent upon performance			$ 7,600,000
RMSpumptools Limited
Business Acquisition [Line Items]
Consideration transferred	$ 106,100,000
Goodwill	45,005,000
Identifiable intangible assets	53,000,000
Business combination, recognized identifiable assets acquired and liabilities assumed, liabilities	29,015,000
Deferred income taxes	$ 13,849,000

ACQUISITIONS, DIVESTITURES AN_4

ACQUISITIONS, DIVESTITURES AND SALE-LEASEBACK - Schedule of Preliminary Allocation of Purchase Price (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jul. 08, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 718,944		$ 669,064	$ 679,488
RMSpumptools Limited
Business Acquisition [Line Items]
Cash and cash equivalents		$ 4,262
Receivables		14,466
Inventories		15,168
Prepaid expenses and other current assets		484
Property, plant, and equipment		1,335
Identifiable intangible assets		53,000
Operating leases right-of-use asset		1,162
Other noncurrent assets		192
Total identifiable assets acquired		90,069
Accounts payable		6,342
Accrued compensation and employee benefits		3,261
Accrued expenses and other current liabilities		4,296
Deferred income taxes		13,849
Operating lease liabilities		1,267
Total liabilities assumed		29,015
Net identifiable assets acquired		61,054
Goodwill		45,005
Total net assets acquired		$ 106,059

REVENUE - Schedule of Disaggreg

REVENUE - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,633,983	$ 3,758,285	$ 3,805,948
United States
Disaggregation of Revenue [Line Items]
Total revenue	2,023,000	1,980,251	1,934,716
Latin America
Disaggregation of Revenue [Line Items]
Total revenue	352,744	560,001	633,487
Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	458,648	426,392	409,890
Canada
Disaggregation of Revenue [Line Items]
Total revenue	403,705	385,574	386,762
Europe
Disaggregation of Revenue [Line Items]
Total revenue	237,973	245,499	245,975
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	83,440	81,002	84,428
Australia
Disaggregation of Revenue [Line Items]
Total revenue	74,473	69,671	56,516
Other
Disaggregation of Revenue [Line Items]
Total revenue	0	9,895	54,174
Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	3,637,379	3,719,398	3,676,848
Corporate and other
Disaggregation of Revenue [Line Items]
Total revenue	(3,396)	38,887	129,100
Corporate and other | United States
Disaggregation of Revenue [Line Items]
Total revenue	0	20,659	76,461
Corporate and other | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	0	1,720	3,100
Corporate and other | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	(3,396)	(1,170)	2,314
Corporate and other | Canada
Disaggregation of Revenue [Line Items]
Total revenue	0	18	116
Corporate and other | Europe
Disaggregation of Revenue [Line Items]
Total revenue	0	5,121	13,936
Corporate and other | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	0	12,539	33,173
Corporate and other | Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0
Corporate and other | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0
Production Chemical Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	2,288,886	2,404,377	2,347,526
Production Chemical Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	1,024,847	983,542	851,057
Production Chemical Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	307,590	522,372	594,737
Production Chemical Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	353,240	325,142	307,154
Production Chemical Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	315,696	296,001	296,623
Production Chemical Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	199,727	196,533	194,034
Production Chemical Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	66,805	48,718	35,536
Production Chemical Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	20,981	22,739	21,866
Production Chemical Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	9,330	46,519
Production & Automation Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	1,042,369	1,003,146	954,646
Production & Automation Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	781,260	763,103	738,178
Production & Automation Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	31,792	22,727	21,756
Production & Automation Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	78,471	65,396	66,918
Production & Automation Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	68,020	73,806	73,561
Production & Automation Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	18,612	17,641	13,655
Production & Automation Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	10,759	13,556	6,170
Production & Automation Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	53,455	46,917	34,318
Production & Automation Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	0	90
Drilling Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	211,828	215,721	229,479
Drilling Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	166,843	163,776	180,912
Drilling Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	221	0	7
Drilling Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	7,565	10,471	6,628
Drilling Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	17,815	14,326	14,529
Drilling Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	15,264	23,401	20,911
Drilling Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	4,120	3,745	6,434
Drilling Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	33
Drilling Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	0	2	25
Reservoir Chemical Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Total revenue	94,296	96,154	145,197
Reservoir Chemical Technologies | Operating Segments | United States
Disaggregation of Revenue [Line Items]
Total revenue	50,050	49,171	88,108
Reservoir Chemical Technologies | Operating Segments | Latin America
Disaggregation of Revenue [Line Items]
Total revenue	13,141	13,182	13,887
Reservoir Chemical Technologies | Operating Segments | Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	22,768	26,553	26,876
Reservoir Chemical Technologies | Operating Segments | Canada
Disaggregation of Revenue [Line Items]
Total revenue	2,174	1,423	1,933
Reservoir Chemical Technologies | Operating Segments | Europe
Disaggregation of Revenue [Line Items]
Total revenue	4,370	2,803	3,439
Reservoir Chemical Technologies | Operating Segments | Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,756	2,444	3,115
Reservoir Chemical Technologies | Operating Segments | Australia
Disaggregation of Revenue [Line Items]
Total revenue	37	15	299
Reservoir Chemical Technologies | Operating Segments | Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 563	$ 7,540

REVENUE - Schedule of Contract

REVENUE - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Contract assets	$ 0	$ 0
Contract liabilities	$ 16,517	$ 27,406

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT, NET - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,604,887	$ 1,554,919
Accumulated depreciation	(849,465)	(781,367)
Property, plant and equipment, net	755,422	773,552
Land and land improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	120,305	126,151
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	286,593	311,436
Software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	66,540	60,945
Machinery, equipment and other
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,131,449	$ 1,056,387

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT, NET - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 190.9	$ 174	$ 154.6

GOODWILL AND INTANGIBLE ASSET_2

GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Goodwill, beginning of period	$ 669,064	$ 679,488
Acquisition	60,754
Foreign currency translation	(10,874)	(10,424)
Goodwill, end of period	718,944	669,064
Production Chemical Technologies
Goodwill [Roll Forward]
Goodwill, beginning of period	356,558	367,084
Acquisition	0
Foreign currency translation	(8,998)	(10,526)
Goodwill, end of period	347,560	356,558
Production & Automation Technologies
Goodwill [Roll Forward]
Goodwill, beginning of period	211,370	211,268
Acquisition	60,754
Foreign currency translation	(1,876)	102
Goodwill, end of period	270,248	211,370
Drilling Technologies
Goodwill [Roll Forward]
Goodwill, beginning of period	101,136	101,136
Acquisition	0
Foreign currency translation	0	0
Goodwill, end of period	101,136	101,136
Reservoir Chemical Technologies
Goodwill [Roll Forward]
Goodwill, beginning of period	0	0
Acquisition	0
Foreign currency translation	0	0
Goodwill, end of period	$ 0	$ 0

GOODWILL AND INTANGIBLE ASSET_3

GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)				12 Months Ended
	Oct. 01, 2024	Oct. 01, 2023	Oct. 01, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment			$ 39,600,000	$ 0	$ 0	$ 39,617,000
Goodwill				718,944,000	669,064,000	679,488,000
Amortization of intangible assets				55,000,000	61,900,000	87,300,000
Production Chemical Technologies
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment	$ 0	$ 0
Goodwill				347,560,000	356,558,000	367,084,000
Production & Automation Technologies
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment	0	0
Goodwill				270,248,000	211,370,000	211,268,000
Drilling Technologies
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment	0	0
Goodwill				101,136,000	101,136,000	101,136,000
Reservoir Chemical Technologies
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 0	$ 0		$ 0	$ 0	$ 0

GOODWILL AND INTANGIBLE ASSET_4

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 572,503	$ 822,386
Accumulated Amortization	318,689	583,633
Net Carrying Amount	253,814	238,753
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	4,800	4,800
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	577,303	827,186
Accumulated Amortization	318,689	583,633
Net Carrying Amount	258,614	243,553
Trademarks
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	3,600	3,600
In-process research and development
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	1,200	1,200
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	324,893	583,326
Accumulated Amortization	177,831	438,181
Net Carrying Amount	147,062	145,145
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	177,831	438,181
Unpatented technologies
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	173,333	142,760
Accumulated Amortization	96,984	75,224
Net Carrying Amount	76,349	67,536
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	96,984	75,224
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	31,575	59,862
Accumulated Amortization	12,335	39,564
Net Carrying Amount	19,240	20,298
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	12,335	39,564
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	35,722	36,438
Accumulated Amortization	30,323	30,664
Net Carrying Amount	5,399	5,774
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	30,323	30,664
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	6,980	0
Accumulated Amortization	1,216	0
Net Carrying Amount	5,764	0
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ 1,216	$ 0

GOODWILL AND INTANGIBLE ASSET_5

GOODWILL AND INTANGIBLE ASSETS - Schedule of Amortization Expense (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2025	$ 46,946
2026	46,588
2027	35,480
2028	25,813
2029	$ 22,312

DEBT - Schedule of Long-term de

DEBT - Schedule of Long-term debt (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Sep. 29, 2023
Debt Instrument [Line Items]
Total	$ 612,559	$ 618,762
Net unamortized discounts and issuance costs	(14,903)	(18,276)
Total long-term debt	597,656	600,486
Current portion of long-term debt	(6,203)	(6,203)
Long-term debt, less current portion	591,453	594,283
Revolving Credit Facility | 2022 Revolving Credit Facility
Debt Instrument [Line Items]
Total	0	0
Term Loan Facility | 2022 Term Loan Facility
Debt Instrument [Line Items]
Total	$ 612,559	$ 618,762	$ 620,300

DEBT - Narrative (Details)

DEBT - Narrative (Details) - USD ($)					12 Months Ended
	Sep. 29, 2023	Jun. 29, 2022	Jun. 07, 2022	Jun. 03, 2020	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023	May 09, 2018	May 03, 2018
Debt Instrument [Line Items]
Total						$ 612,559,000	$ 618,762,000
Interest rate swaps | Designated as Hedging Instrument
Debt Instrument [Line Items]
Derivative, term of contract (in years)		5 years
Interest Rate Swap, First Three Years | Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps		$ 300,000,000
Interest Rate Swap, Years Four And Five | Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps		$ 150,000,000
2022 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued			$ 625,000,000
Debt instrument, term (in years)			7 years
Total	$ 620,300,000					612,559,000	$ 618,762,000
Mandatory amortization payment, percent per annum			1%
2022 Term Loan Facility | Term Loan Facility | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
2022 Term Loan Facility | Term Loan Facility | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
2022 Revolving Credit Facility | Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)			5 years
Maximum borrowing capacity			$ 700,000,000
Proceeds from lines of credit			135,000,000
Total						$ 0
2022 Revolving Credit Facility | Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 100,000,000
6.375% Senior Notes due 2026 | Senior Notes
Debt Instrument [Line Items]
Principal amount of debt issued									$ 300,000,000
Debt interest rate			6.375%
Redemption price, percentage of principal amount of debt			103.188%
Aggregate principal amount repurchased			$ 92,000,000
Payments to repurchase debt, cash payments			95,600,000
Payments to repurchase debt, accrued interest			$ 600,000
Loss on repurchase of debt					$ 3,900,000
2020 Term Loan Facility
Debt Instrument [Line Items]
Payments to fund merger				$ 527,400,000
2020 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued				$ 537,000,000
2018 Term Loan Facility | Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued								$ 415,000,000

DEBT - Schedule of Aggregate Co

DEBT - Schedule of Aggregate Contractual Future Principal Payments (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 6,203
2026	6,203
2027	6,203
2028	6,203
2029	587,747
Total	$ 612,559

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) location	Dec. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Outstanding letters of credit	$ 70.3	$ 70.7
Environmental loss contingency, noncurrent, statement of financial position, extensible enumeration, not disclosed flag	true	true
Accrued liabilities for remediation	$ 5.7	$ 5.9
Environmental exit costs, assets previously disposed, liability for remediation	$ 1.8
Environmental Assessments and Remediation
Loss Contingencies [Line Items]
Number of locations with environmental matters (in locations) | location	8
Ecolab
Loss Contingencies [Line Items]
Payments made under supply agreements	$ 25

LEASES - Schedule of Balance Sh

LEASES - Schedule of Balance Sheet Information (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Mar. 29, 2024	Dec. 31, 2023
Leases [Abstract]
Finance lease, right-of-use asset	$ 54,025		$ 41,554
Operating lease right-of-use assets	100,427	$ 37,700	69,561
Total lease right-of-use assets	154,452		111,115
Finance leases - current	14,688		11,723
Finance leases	41,586		31,202
Current portion of operating lease liabilities	16,794		23,292
Operating lease liabilities	81,340		41,975
Total lease liability	$ 154,408		$ 108,192
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities		Accrued expenses and other current liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities		Other long-term liabilities

LEASES - Schedule of Lease Cost

LEASES - Schedule of Lease Cost and Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Finance lease cost, amortization of right-of-use assets	$ 14,946	$ 11,114
Finance lease cost, interest on lease liabilities	3,792	2,480
Operating lease cost	32,809	35,163
Short-term and variable lease cost	13,582	18,845
Sublease income	(300)	0
Total lease cost	$ 64,829	$ 67,602
Operating lease, weighted-average remaining lease term (in years)	12 years 6 months	7 years 1 month 6 days
Finance lease, weighted-average remaining lease term (in years)	4 years 2 months 12 days	4 years 1 month 6 days
Operating lease, weighted-average discount rate (in percent)	7.80%	6.40%
Finance lease, weighted-average discount rate (in percent)	7.70%	7.30%

LEASES - Schedule of Future Min

LEASES - Schedule of Future Minimum Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Mar. 29, 2024
Operating
2025	$ 23,476
2026	17,453
2027	13,625
2028	9,842
2029	8,240
Thereafter	87,179
Total future minimum lease payments	159,815
Interest included within lease payments	(61,681)
Total lease liabilities	98,134	$ 37,700
Finance
2025	18,099
2026	15,367
2027	14,086
2028	10,324
2029	4,729
Thereafter	2,856
Total future minimum lease payments	65,461
Interest included within lease payments	(9,187)
Total lease liabilities	$ 56,274

LEASES - Narrative (Details)

LEASES - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Lease revenue	$ 103.5	$ 84.2
Equipment Leased Assets
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 81.5	$ 67.4
Minimum
Property, Plant and Equipment [Line Items]
Lessor, term of leases	12 months
Maximum
Property, Plant and Equipment [Line Items]
Lessor, term of leases	14 months

LEASES - Schedule of Leased Ass

LEASES - Schedule of Leased Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	$ 1,604,887	$ 1,554,919
Accumulated depreciation	(849,465)	(781,367)
Property, plant and equipment, net	755,422	$ 773,552
Equipment Leased Assets
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	277,360
Accumulated depreciation	(163,531)
Property, plant and equipment, net	$ 113,829
Cable equipment
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)	18 months
Property, plant, and equipment	$ 67,945
Downhole equipment
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)	18 months
Property, plant, and equipment	$ 68,164
Surface equipment
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)	5 years
Property, plant, and equipment	$ 122,792
Other lease equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment	$ 18,459
Minimum | Other lease equipment
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)	3 years
Maximum | Other lease equipment
Property, Plant and Equipment [Line Items]
Useful life of property, plant and equipment (in years)	5 years

RESTRUCTURING - Narrative (Deta

RESTRUCTURING - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring charges	$ 11,330	$ 6,294	$ 68,102

RESTRUCTURING - Schedule of Res

RESTRUCTURING - Schedule of Restructuring and Other Related Charges (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 11,330	$ 6,294	$ 68,102
Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag	Total	Total	Total
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of goods and services	Cost of goods and services	Cost of goods and services
Cost of goods and services
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 4,998	$ 2,571	$ 47,216
Selling, general and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring charges	6,332	3,723	20,886
Operating Segments | Production Chemical Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	6,023	4,662	13,899
Operating Segments | Production & Automation Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	5,073	770	1,111
Operating Segments | Drilling Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	234	0	0
Operating Segments | Reservoir Chemical Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	856	47,692
Corporate and other
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0	$ 6	$ 5,400

RESTRUCTURING - Schedule of R_2

RESTRUCTURING - Schedule of Restructuring Reserve Rollforward (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 13,974
Restructuring charges	11,330
Write-offs	(3,805)
Payments	(9,027)
Ending balance	$ 12,472

EMPLOYEE BENEFIT PLANS (Details

EMPLOYEE BENEFIT PLANS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Net actuarial (loss) gain arising during period	$ (0.8)	$ (0.5)	$ 2.9
Unfunded liability	8.9	9.3
Defined benefit plan, net periodic benefit expense	$ 1.1	$ 0.9	$ 1.3

EQUITY AND CASH INCENTIVE PRO_3

EQUITY AND CASH INCENTIVE PROGRAMS - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved and authorized for issuance (in shares)				31,400,000	18,200,000
Compensation costs	$ 19,982,000	$ 18,439,000	$ 15,597,000
Unrecognized compensation costs related to options	0
Total intrinsic value of stock options exercised	10,300,000
Proceeds from stock options exercised	2,300,000
Tax benefit from stock options exercised	$ 2,000,000
SARs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Expiration period	10 years
Unrecognized compensation expense not yet exercisable	$ 0
Performance shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Unrecognized compensation expense not yet exercisable	$ 9,900,000
Granted (in shares)	271,190
Weighted average period (in years)	1 year 8 months 12 days
Performance shares | Market Vesting Conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Granted (in shares)	271,190	244,120	347,920
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	4 years
Restricted Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Restricted Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	4 years
Restricted Stock, Restricted Stock Units, Directors’ Shares and Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense not yet exercisable	$ 20,400,000
Granted (in shares)	644,320
Weighted average period (in years)	10 months 24 days

EQUITY AND CASH INCENTIVE PRO_4

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based compensation expense	$ 25,770	$ 23,749	$ 20,089
Tax benefit	(5,788)	(5,310)	(4,492)
Stock-based compensation expense, net of tax	$ 19,982	$ 18,439	$ 15,597

EQUITY AND CASH INCENTIVE PRO_5

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Activity Relating to SARs Outstanding (Details) - SARs $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Shares
Number of shares outstanding, beginning of the period (in shares) | shares	235,125
Forfeited / expired (in shares) | shares	(19,422)
Exercised (in shares) | shares	(10,834)
Number of shares outstanding, end of the period (in shares) | shares	204,869
Number of shares, exercisable (in shares) | shares	204,869
Weighted-Average Exercise Price
Weighted average exercise price outstanding, beginning of the period (in dollars per share) | $ / shares	$ 31.89
Forfeited / expired (in dollars per share) | $ / shares	35.53
Exercised (in dollars per share) | $ / shares	33.22
Weighted average exercise price outstanding, end of the period (in dollars per share) | $ / shares	31.47
Weighted average exercise price exercisable (in dollars per share) | $ / shares	$ 31.47
Weighted average remaining contractual term, outstanding (years)	1 year 7 months 6 days
Weighted average remaining contractual term, exercisable (in years)	1 year 7 months 6 days
Aggregate intrinsic value | $	$ 117
Aggregate intrinsic value, exercisable | $	$ 117

EQUITY AND CASH INCENTIVE PRO_6

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Other Information Regarding the Exercise of SARs (Details) - SARs - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of SARs that became exercisable	$ 0	$ 0	$ 0
Aggregate intrinsic value of SARs exercised	$ 37	$ 169	$ 634

EQUITY AND CASH INCENTIVE PRO_7

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Activity for Performance Share Awards (Details) - Performance shares	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Number of shares outstanding, beginning of the period (in shares) | shares	901,661
Granted (in shares) | shares	271,190
Forfeited (in shares) | shares	(4,310)
Vested (in shares) | shares	(511,602)
Performance adjustment (in shares) | shares	150,319
Number of shares outstanding, end of the period (in shares) | shares	807,258
Weighted-Average Grant-Date Fair Value
Weighted average grant-date fair value, outstanding beginning of the period (in dollars per share) | $ / shares	$ 26.04
Granted (in dollars per share) | $ / shares	32.65
Forfeited (in dollars per share) | $ / shares	28.54
Vested (in dollars per share) | $ / shares	21.99
Performance adjustment (in dollars per share) | $ / shares	21.97
Weighted average grant-date fair value, outstanding end of the period (in dollars per share) | $ / shares	$ 29.60
Vesting period (in years)	3 years

EQUITY AND CASH INCENTIVE PRO_8

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Activity for Restricted Stock Units (Details) - Restricted Stock, Restricted Stock Units, Directors’ Shares and Deferred Stock Units	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Number of shares outstanding, beginning of the period (in shares) | shares	1,537,044
Granted (in shares) | shares	644,320
Forfeited (in shares) | shares	(111,281)
Vested (in shares) | shares	(644,034)
Number of shares outstanding, end of the period (in shares) | shares	1,426,049
Weighted-Average Grant-Date Fair Value
Weighted average grant-date fair value, outstanding beginning of the period (in dollars per share) | $ / shares	$ 24.37
Granted (in dollars per share) | $ / shares	30.14
Forfeited (in dollars per share) | $ / shares	26.99
Vested (in dollars per share) | $ / shares	22.78
Weighted average grant-date fair value, outstanding end of the period (in dollars per share) | $ / shares	$ 27.44

EQUITY AND CASH INCENTIVE PRO_9

EQUITY AND CASH INCENTIVE PROGRAMS - Schedule of Non-Qualified Stock Options (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Shares
Options outstanding, balance at the beginning of the period (in shares) | shares	2,728,376
Options granted (in shares) | shares	0
Options forfeited/expired (in shares) | shares	0
Options exercised (in shares) | shares	(378,195)
Options outstanding, balance at the end of the period (in shares) | shares	2,350,181
Options exercisable (in shares) | shares	2,350,181
Weighted Average Exercise Price
Options outstanding, balance at the beginning of the period (in dollars per share) | $ / shares	$ 6.41
Options granted (in dollars per share) | $ / shares	0
Options forfeited/expired (in dollars per share) | $ / shares	0
Options exercised (in dollars per share) | $ / shares	6
Options outstanding, balance at the end of the period (in dollars per share) | $ / shares	6.47
Options exercisable, weighted-average exercise price (in dollars per share) | $ / shares	$ 6.47
Weighted-average remaining contractual term, outstanding at end of period (in years)	2 years 4 months 24 days
Options exercisable, weighted average remaining contractual term (in years)	2 years 4 months 24 days
Aggregate intrinsic value, at end of period | $	$ 48,373
Aggregate intrinsic value, options | $	$ 48,373

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)			3 Months Ended	12 Months Ended
	Jan. 31, 2025	Jan. 31, 2024	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Oct. 24, 2022	Mar. 07, 2022
Class of Stock [Line Items]
Approved quarterly cash dividend (in dollars per share)		$ 0.095
Dividends declared to common shareholders (in dollars per share)			$ 0.095	$ 0.38	$ 0.34	$ 0.30
Dividends payable			$ 19,000,000	$ 19,000,000
Authorized amount of stock repurchase		$ 1,500,000,000					$ 750,000,000	$ 250,000,000
Repurchase and cancellation of common stock (in shares)				1,611,055
Value of repurchased common stock				$ 49,399,000	$ 277,575,000	$ 180,142,000
Subsequent Event
Class of Stock [Line Items]
Quarterly cash dividend on common stock (in dollars per share)	$ 0.095

EARNINGS PER SHARE - Schedule o

EARNINGS PER SHARE - Schedule of Reconciliation of the Shares Used in EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Net income attributable to ChampionX	$ 320,266	$ 314,238	$ 154,969
Weighted-average number of shares outstanding (in shares)	190,578	196,083	201,740
Dilutive effect of stock-based compensation (in shares)	3,065	3,823	5,519
Total shares and dilutive securities (in shares)	193,643	199,906	207,259
Basic earnings per share attributable to ChampionX (in dollars per share)	$ 1.68	$ 1.60	$ 0.77
Diluted earnings per share attributable to ChampionX (in dollars per share)	$ 1.65	$ 1.57	$ 0.75

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Potentially diluted securities excluded as anti-dilutive (in shares)	0.2	0.3	0.4

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Assets
Derivative assets	$ 14,277	$ 11,830
Liabilities
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Liabilities
Derivative liabilities	$ 13,443	5,354
Fair Value, Recurring
Assets
Derivative assets	14,277	11,830
Liabilities
Derivative liabilities	13,443	5,354
Fair Value, Recurring | Foreign currency forward contracts | Level 2
Assets
Derivative assets	10,078	6,231
Liabilities
Derivative liabilities	13,430	5,354
Fair Value, Recurring | Interest rate swaps | Level 2
Assets
Derivative assets	4,199	5,599
Liabilities
Derivative liabilities	$ 13	$ 0

FAIR VALUE MEASUREMENTS - Sch_2

FAIR VALUE MEASUREMENTS - Schedule of Fair Value of Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	$ 612,559	$ 618,762
Level 2 | Credit Facility | 2022 Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	0	0
Fair Value	0	0
Level 2 | Term Loan | 2022 Term Loan Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	612,559	618,762
Fair Value	$ 613,324	$ 623,402

DERIVATIVES AND HEDGING TRANS_3

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Derivative Assets
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other current assets	Prepaid expenses and other current assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Derivative asset, current	$ 12,455	$ 11,004
Derivative asset, noncurrent	1,822	826
Derivative assets	$ 14,277	$ 11,830
Derivative Liabilities
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities	Other long-term liabilities
Derivative liability, current	$ 13,443	$ 5,354
Derivative liability, noncurrent	0	0
Derivative liabilities	$ 13,443	$ 5,354

DERIVATIVES AND HEDGING TRANS_4

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Foreign Exchange Forward Contracts and Interest Rate Swap
Derivative [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 941,784	$ 892,711

DERIVATIVES AND HEDGING TRANS_5

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Loss on Derivative Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss (gain) on derivative instruments	$ (2,364)	$ (6,410)	$ 6,031
Cost of goods and services | Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss (gain) on derivative instruments	(1,023)	(2,571)	(1,665)
Interest expense | Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss (gain) on derivative instruments	(6,399)	(5,034)	549
Foreign currency transaction losses, net | Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss (gain) on derivative instruments	$ 5,058	$ 1,195	$ 7,147

INCOME TAXES - Schedule of Comp

INCOME TAXES - Schedule of Components of Income (Loss) Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Domestic	$ 243,620	$ 304,725	$ 58,141
Foreign	199,255	119,099	138,665
Income before income taxes	$ 442,875	$ 423,824	$ 196,806

INCOME TAXES - Schedule of Prov

INCOME TAXES - Schedule of Provision for (Benefit From) Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current:
U.S. federal	$ 76,037	$ 74,022	$ 49,997
State and local	8,534	9,234	11,147
Foreign	54,048	44,121	24,381
Total current	138,619	127,377	85,525
Deferred:
U.S. federal	(22,880)	(17,219)	(35,207)
State and local	(1,020)	(3,198)	(4,900)
Foreign	1,027	(1,855)	(5,175)
Total deferred	(22,873)	(22,272)	(45,282)
Provision for income taxes	$ 115,746	$ 105,105	$ 40,243

INCOME TAXES - Schedule of Effe

INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Statutory U.S. federal income tax rate	21%	21%	21%
State and local taxes, net of federal income tax benefit	0.90%	1.10%	0.60%
Foreign withholding tax	4.20%	4%	5.70%
Foreign derived intangible income	(1.00%)	(1.90%)	(1.00%)
Foreign operations tax effect	(1.40%)	2.10%	2.80%
Research and experimentation tax credits	(1.30%)	(1.30%)	(1.50%)
Foreign tax credit	(1.20%)	(3.90%)	(4.50%)
Nondeductible expenses	0%	0.20%	0.50%
Branch income	1.50%	1.20%	3.50%
Tax return to accrual adjustments	(0.30%)	(1.60%)	(2.10%)
State deferred taxes	0.20%	(0.20%)	(1.00%)
Goodwill impairment	0%	0%	1.80%
Foreign inclusions (including global intangible low-taxed income)	0.50%	4.30%	3.50%
Change in valuation allowance	2.80%	0.80%	(7.30%)
Stock compensation	(1.90%)	(2.10%)	(3.60%)
Nondeductible officer compensation	0.90%	0.70%	0.80%
Other	1.20%	0.40%	1.20%
Effective income tax rate	26.10%	24.80%	20.40%

INCOME TAXES - Schedule of Co_2

INCOME TAXES - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets attributable to:
Accrued compensation	$ 13,654	$ 10,558
Accrued expenses	9,118	6,565
Inventories	3,146	4,674
Net operating loss and other carryforwards	37,928	31,355
Accounts receivable	13,646	13,401
Lease liability	14,404	7,198
Research and Development	41,202	31,324
Other assets	7,167	1,258
Deferred tax assets	140,265	106,333
Valuation allowance	(45,992)	(33,031)
Deferred tax assets, net of valuation allowance	94,273	73,302
Deferred tax liabilities attributable to:
Inventories	(1,142)	(3,462)
Intangible assets, including goodwill	(51,318)	(38,651)
Property, plant and equipment	(56,072)	(65,559)
Foreign withholding taxes	(19,650)	(15,934)
Lease asset	(15,308)	(7,012)
Investment in subsidiary	(2,724)	(1,950)
Long-term liabilities	(2,653)	(3,128)
Deferred tax liabilities	(148,867)	(135,696)
Net deferred tax liabilities	(54,594)	(62,394)
Other non-current assets	7,779	9,103
Deferred income taxes	$ (62,373)	$ (71,497)

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Valuation Allowance [Line Items]
Effective income tax rate	26.10%	24.80%	20.40%
Net operating loss carryforwards, foreign	$ 9,400
Foreign tax credit carryforwards	30,600
Valuation allowance	45,992	$ 33,031
Provision for income taxes	115,746	105,105	$ 40,243
Accrued foreign withholding taxes on undistributed foreign earnings	19,650	15,934
Foreign Deferred Tax Assets
Valuation Allowance [Line Items]
Valuation allowance	$ 18,900
Foreign Tax Credits
Valuation Allowance [Line Items]
Valuation allowance		$ 27,100

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Proceeds from sale of inventory to related parties	$ 33.9
Unconsolidated Majority-Owned Subsidiary | Apergy Middle East Services LLC
Related Party Transaction [Line Items]
Payments of ordinary dividends, noncontrolling interest	0.8	$ 1.9	$ 1.2
Unconsolidated Majority-Owned Subsidiary | Champion Arabia Co Ltd
Related Party Transaction [Line Items]
Payments of ordinary dividends, noncontrolling interest	4.8	0.7	1.3
Unconsolidated Majority-Owned Subsidiary | Petrochem Performance Products
Related Party Transaction [Line Items]
Payments of ordinary dividends, noncontrolling interest	$ 0.9	$ 0.1	$ 0.2

ACCOUNTS RECEIVABLE FACILITIES

ACCOUNTS RECEIVABLE FACILITIES (Details) - Accounts Receivable Held For Sale Under Accounts Receivable Facility $ in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 28, 2024 USD ($)	Mar. 28, 2024 CAD ($)	Jun. 28, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable purchase agreement, maximum amount to be sold			$ 30	$ 40	$ 160
Accounts receivable sold	$ 631.1
JPMorgan Chase Bank
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable facility, outstanding amount sold	84.8
Loss on sale of trade receivable	6.8	$ 7.1
HSBC
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable sold	98.2
Accounts receivable facility, outstanding amount sold	19.4
Loss on sale of trade receivable	$ 0.9

SUPPLY CHAIN FINANCE - Narrativ

SUPPLY CHAIN FINANCE - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Supply chain finance outstanding	$ 30,584	$ 30,783
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]	Accounts Payable, Current

SUPPLY CHAIN FINANCE - Schedule

SUPPLY CHAIN FINANCE - Schedule of Supply Chain Finance Payables (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Supplier Finance Program, Obligation [Roll Forward]
Beginning Balance	$ 30,783
Purchases	186,479
Payments	(186,390)
Other, including foreign currency translation	(288)
Ending Balance	$ 30,584

CASH FLOW INFORMATION - Schedul

CASH FLOW INFORMATION - Schedule of Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Cash paid for income taxes	$ 78,163	$ 116,677	$ 127,271
Cash paid for interest	52,118	57,267	46,781
Net increase (decrease) in accounts payable for capital expenditures	$ (7,795)	$ 4,321	$ (6,803)

CASH FLOW INFORMATION - Sched_2

CASH FLOW INFORMATION - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Operating leases	$ 32,155	$ 35,297
Finance leases - interest	3,792	2,480
Finance leases - principal	13,838	9,982	$ 6,540
Operating leases	52,265	4,197
Finance leases	$ 23,034	$ 31,113

CASH FLOW INFORMATION - Narrati

CASH FLOW INFORMATION - Narrative (Details) $ in Thousands	3 Months Ended		6 Months Ended	12 Months Ended
	Dec. 31, 2024 instrument	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Inventory transferred into property, plant, and equipment				$ 110,700	$ 105,000	$ 80,200
Expenditures for assets expected to be placed in lease asset program				46,000	58,200	39,800
Loss on Argentina Blue Chip Swap transaction				7,086	$ 0	$ 0
ARGENTINA
Property, Plant and Equipment [Line Items]
Foreign currency exchange rate, period remeasurement		29%	29%
Loss on Argentina Blue Chip Swap transaction				$ 7,100
Derivative, number of instruments entered | instrument	0

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts - Allowance for Doubtful Accounts (Details) - Allowance for Doubtful Accounts - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 5,734	$ 5,506	$ 7,662
Charged to Cost and Expense	395	1,480	(927)
Accounts Written Off	(1,094)	(1,244)	(869)
Other	83	(8)	(360)
Balance at End of Year	$ 5,118	$ 5,734	$ 5,506

Schedule II - Valuation and Q_3

Schedule II - Valuation and Qualifying Accounts - Deferred Tax Valuation Allowance (Details) - Deferred Tax Valuation Allowance - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 33,031	$ 32,500	$ 38,716
Additions	13,135	472	0
Reductions	0	0	(6,120)
Other	(174)	59	(96)
Balance at End of Year	$ 45,992	$ 33,031	$ 32,500

Schedule II - Valuation and Q_4

Schedule II - Valuation and Qualifying Accounts - LIFO and Inventory Valuation Adjustments (Details) - Inventory Reserves (including LIFO) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 78,205	$ 87,238	$ 78,923
Additions	15,199	18,974	26,306
Reductions	(13,238)	(27,578)	(16,566)
Other	(679)	(429)	(1,425)
Balance at End of Year	$ 79,487	$ 78,205	$ 87,238